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Abstract 
 
 The immune system is a complex network of interacting cells and tissues 
that is designed to protect the body from pathogens and other foreign 
substances.  T cells are a major component of the immune system and consist of 
two distinct lineages distinguished by the expression of αβ or γδ T cell receptors 
(TCR).  The Tec family kinase, Itk is an important mediator of signaling 
downstream of the TCR.  Past studies on Itk has focused on how Itk regulates 
development, activation and differentiation of conventional αβ T cells and more 
recently how Itk regulates the development of innate-like αβ T cells.  However, 
very little is known about the influence of Itk on γδ T cells.  My studies show a 
previously unknown role for Itk in the development and function of γδ T cells.  We 
report in the absence of Itk, γδ T cells were responsible for the spontaneously 
elevated levels of serum IgE and Itk-/- mice γδ T cells produced high levels of TH2 
cytokines.  Furthermore, there was an increase in γδ T cells specifically in the 
Vγ1.1+Vδ6.3+ (V6) subset that represents the dominant population of γδ NKT cells 
in Itk-/- mice.  In addition, the V6 subset had increased expression of PLZF, a 
transcription factor normally required for αβ iNKT cell development.  We further 
show that V6 cells develop and mature similar to αβ iNKT cells.  Similar to 
defects previously seen in the terminal differentiation of Itk-/- αβ iNKT cell, V6 
cells also had impaired maturation in the thymus in the absence of Itk.  This data 
vii
demonstrates a previously unknown role of Itk for the terminal maturation of V6 
cells that has been shown to be the cell population that led to spontaneous 
dermatitis in mice.  Given that drug companies have targeted Itk as a potential 
allergy drug due to Itk’s role in TH2 development and function, our data suggests 
that further studies on Itk are warranted. 
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Chapter I: Introduction 
 
 
 
 
 
 
 
 
 
 
 
2Immunoglobulin E-mediated diseases 
 
 The last four decades has seen an increase in the prevalence of 
immunoglobulin E (IgE)-mediated diseases including hyper IgE syndrome (HIES) 
and allergies in the western world.  A similar increase in IgE-mediated diseases 
has also manifested in developing countries such as India and China.  Found in 
most mammals and marsupials, IgE normally plays a role in the defense against 
multicellular parasites (1).  However, fatal anaphylaxis or severe asthma can 
develop 5-10 minutes after exposure to allergens during an IgE-mediated 
response.  This IgE mediated response is normally mounted when dendritic cells 
differentiate and promote the formation of allergen-specific T helper type 2 (TH2) 
cells which produce the cytokines IL-4 and IL-13.  These cytokines are necessary 
for B cells to class switch and become IgE-producing plasma cells (2).  Secreted 
IgE is able to bind to the high affinity IgE receptor, FcεR1, on mast cells and 
eosinophils.  Activation of these cells in response to specific allergens can result 
in systemic anaphylaxis (3).  Therefore, It has been suggested that synthesizing 
drugs to regulate the development and/or function of TH2 cells may be an 
attractive target for asthma (4).  In addition, studies in mouse models lacking 
molecules critical for proper T cell function such as Itk (inducible T-cell kinase) 
and Itch mutants, have hyper IgE syndrome making them ideal models to study.  
Furthermore, a recent case study involving a patient with HIES demonstrated 
that another T cell subset, γδ T cells, was able to generate high levels of IL-4 that 
3contributed to elevated IgE in the serum (5).  Various studies performed in mice 
have also indicated that γδ T cells are able to provide help to B cells that can lead 
to IgE class switching (6-8).  Taken together this data indicates that TH2 cells 
may not be the only T cell type able to promote B cell IgE class switching.  The 
work presented here will focus on the development and function of γδ T cells with 
respect to the signaling molecule Itk. 
 
γδ T cells: interface between adaptive and innate immunity  
 
 γδ T cells are a subset of T cells constituting 1-5% of lymphocytes in the 
blood and peripheral organs yet they comprise over half of the lymphocytes 
found in the reproductive tract, skin and intestine.  Within the epithelial tissues, γδ
T cells are the first line of defense and can assist in wound repair (9).  αβ T cells 
are another subset of T cells and are part of the adaptive immune system.  
Although T cells are commonly associated with the adaptive immune system, γδ 
T cells only share a handful of features with their αβ T cell counterparts (Figure 
1.1).  For example, cells that comprise the adaptive immune system are 
characterized by somatic rearranged receptors that require the enzyme 
recombination activating gene (RAG).  RAG mediated recombination joins the 
variable (V) gene segments with joining (J) segments and diversity (D) segments 
thereby allowing for diverse receptors and recognition of very specific antigens  
for T cells.  αβ T cells respond with delayed kinetics to pathogens and can form  
4Figure 1.1 Cells of the adaptive and innate immune system 
The two categories of the immune system are the innate and adaptive immune 
system.  Innate cells have germ line encoded receptors and respond within the 
first few hours upon infection.  Adaptive cells have somatic rearranged receptors 
thereby producing few cells that can recognize specific pathogens during 
infection.  During primary infection adaptive cells have a delayed response 
because only a few cells can recognize a specific pathogen and need to expand, 
but upon clearance of the infection adaptive cells can form memory.  Therefore 
upon secondary infection with the same pathogen adaptive cells can respond 
much faster.  Innate-like lymphocytes such as γδ T cells and αβ iNKT cells have 
characteristics of both innate and adaptive immune cells where they have an 
invariant receptor, respond to infection rapidly and have a memory phenotype. 
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6memory that allow for faster response kinetics upon secondary infection.  
However, not all T cells, such as αβ iNKT cells and γδ T cells fall into the 
adaptive branch of the immune system.  Human γδ T cells are similar to CD4+ T 
cells, another subset of T cells, in that they are able to up-regulate co-stimulatory 
molecules involved in B cell help, a characteristic of the adaptive immune 
response (10).   Both αβ iNKT cells and γδ T cells have an invariant receptor that 
requires RAG mediated VDJ recombination but they cannot form memory, 
although they display an activated or memory-like phenotype meaning that they 
share features normally associated with memory or activated cells such as high 
expression of CD44.  Unlike αβ T cells, αβ iNKT cells and γδ T cells respond 
rapidly to infection which is a characteristic of cells belonging to the second 
branch of the immune system, the innate immune system.  In contrast to the 
adaptive immune system, cells belonging to the innate immune system have 
germ line encoded receptors and recognize microbes by conserved components.  
Cells of the innate system respond to a broad set of pathogens.  In addition, 
innate immune cells cannot form memory and respond to primary and secondary 
infection with equally fast kinetics (11).  γδ and αβ iNKT cells bridge the adaptive 
and innate immune system and plays an important role in providing a fast 
primary response to antigen specific pathogens and priming the adaptive 
immune system.  
T cell development
7 
 All T cells develop from a common precursor during hematopoiesis before 
differentiating into distinct cell types.  Thymocyte development can be tracked 
through stages by alterations in various cell surface markers such as the T cell   
receptor (TCR), CD4, CD8, CD25, CD44 and CD117 (c-kit) with each successive 
stage decreasing the potential to differentiate into other lineages.  The model for 
T cell development begins with the thymic seeding progenitor (TSP), which are 
lymphoid committed (12), migrate to the thymus and become CD4-CD8- double 
negative (DN) cells.  This population can be further subdivided into four 
populations (DN1-4) based upon the surface expression of CD44 and CD25 
(DN1: CD44+CD25-, DN2: CD44+CD25+, DN3: CD44-CD25+, DN4: CD44-CD25-) 
(13, 14).  The DN populations can also be further subdivided based upon CD117 
expression.  DN cells then become CD4+CD8+ double positive (DP) cells, which 
are committed to the αβ T cell lineage before further maturing into either CD4+ 
single positive (SP) or CD8+ SP αβ T cells (15).  During transition through the DN 
stages, rearrangement of TCRγ, TCRδ, and TCRβ gene is initiated at the DN2 
stage (16, 17) and is completed at the DN3 stage (17, 18).  Cells that express a 
functional pre-TCR, which consists of a correctly rearranged TCRβ chain and 
pre-Tα chain, transit to DN4 stage where the TCRα chain begins to rearrange.  
This process of selecting for a correctly rearranged TCRβ chain is called β-
selection.  Upon rearrangement of the TCRα chain during the DP stage αβ T 
cells undergo positive selection where cells are selected by ligands presented by 
8the major histocompatibility complex (MHC).  Cells then transition to become SP 
cells (19-21) where negative selection occurs which deletes self-reactive αβ T 
cells (20).  γδ T cells diverge from αβ T cells development during the DN stages 
though, the exact point where the separation occurs is unclear due to DN2-DN4 
cells retaining the ability to develop into γδ T cells (22-24).   
 
γδ T cell development 
The mechanism of how γδ and αβ T cells diverge is unclear.  Two models 
have been suggested to explain γδ and αβ T cell lineage commitment: the signal 
strength model and the stochastic model.  The signal strength model proposes 
that the T cell receptor determines lineage fate.  In this model, stronger signals 
are thought to favor γδ T cell development where weaker signals favor αβ T cell 
development (25-27).  In contrast, the stochastic model proposes that the TCR 
enforces lineage decision but is not the main determinant.  Instead, in this model 
commitment occurs prior to TCR expression and molecular programs decide γδ 
versus αβ lineage fate (23, 24, 28).  The main difficulty in resolving which model 
is correct is due to the lack of known selecting ligands for γδ T cells.  Even 
though it is unclear the exact moment αβ and γδ T cell development diverges 
more is known about the generation of γδ T cell. 
9 A single Vγ and Vδ gene encodes the receptor repertoires of γδ T cells.  
Murine γ genes are located on chromosome 13 while the Vδ genes comprising of 
the constant (C)δ, Jδ, and Dδ gene segments are located on chromosome 14 
between the Vα and Jα gene segments.  The Vγ genes are often organized as 
clusters with the Cγ genes where Vγ5,Vγ2,Vγ4,Vγ3/Jγ1Cγ1 comprise one cluster 
while Vγ1.1/Jγ4Cγ4 is another cluster (29).  γδ T cells begin to develop during 
embryonic day 14 (E14), which is three days before αβ T cells begin to develop.  
Certain γδ subsets encoded by specific Vγ gene segments are exported from the 
fetal and adult thymus at defined periods as shown in figure 1.2 (30).  At E14 
through E17, Vγ3+ cells are the first lymphocytes to develop.  After E17, 
development of Vγ3+ cells is completed and can no longer be found in the fetal or 
adult thymus but can only be found in the skin.  Following the development of 
Vγ3+ T cells, Vγ4+ T cells develop around E14 through E20 and home to the 
uterus, lung and tongue.  Vγ2+ and Vγ5+ cells arise around E16 and migrate to 
the lungs and gut, respectively.  Interestingly a small population of Vγ5+ cells are 
thought to also develop extra thymically (31) and they consist of half of the cells 
in the gut (32).  Finally Vγ1.1+ cells begin to develop near the end of gestation at 
E18 and continue to develop in the adult thymus along with the Vγ2+ and Vγ5+ 
cells.  Vγ1.1+ cells preferentially home to the liver, but can also be found in the 
spleen and lymph nodes (33-35).  γδ T cells play a diverse role in the immune 
system including wound healing, tumor surveillance along with contributing  
10
Figure 1.2 Generation of αβ and γδ  T cells
Representation of the generation of γδ T cells and αβ T cells in the thymus.  γδ T 
cell receptors are encoded by specific Vγ- gene segments and leave the thymus 
in waves.  As illustrated, γδ T cells are the first lymphocytes to develop in the 
thymus around embryonic day 14 where as αβ T cells do not begin to develop 
until around embryonic day 17.  Each γδ T cell subset preferentially migrates to 
specific organs upon leaving the thymus as indicated underneath the graph. 
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to clearance of infections from viral, bacterial and fungal infections (36-39). 
 
Heterogeneity in selection, function and surface expression within Vγ  
subsets 
 
 Unlike αβ T cells, which require ligand dependent signaling through MHC 
complexes (40) few ligands have been discovered for γδ T cells and it is unclear 
if ligands are required for γδ T cell development.  The few selecting ligands that 
are known for γδ T cells include the γδ T cell clones KN6 and G8 which are 
recognized by the nonclassical MHC class 1b molecules T10 and T22 (41-43).  
T10/T22 specific γδ T cells, consists of 0.1%-1% of the total γδ T cell population 
(44) and express different Vγ chains (42)  Many studies use KN6 γδ T cell 
transgenic mice to examine γδ T cell lineage fate (26, 44) but several caveats to 
this model system exist including T10/T22 specific γδ T cells consisting of only a 
minor portion of γδ T cells and therefore may not be representative of the entire 
population.  In addition, one study demonstrated with the T10/T22 model that the 
function depended on if cells were selected.  This study showed that γδ cells that 
were selected by the nonclassical MHC molecules T10/T22 were ligand-
experienced and secreted IFNγ and γδ cells that were not selected were ligand-
naïve and secreted IL-17 (44).  Another population of γδ T cells that is known to 
require ligand selection are the dendritic epidermal T cells (DETC), which 
13
express the invariant Vγ3Vδ1 (V3) receptor (45, 46).  Recent studies have shown 
that V3 cells require the immunoglobulin-like protein Skint1, which is expressed 
on thymic epithelial cells and in the skin, for selection (47, 48).  Overall, it seems 
that different subsets of γδ T cells may have different selection requirements that 
may or may not require ligand for selection.  In addition to certain subsets of γδ T 
cells requiring ligand for selection, there also seems to be a substantial amount 
of heterogeneity in γδ T cell function. 
 γδ T cell function can be divided into subsets based upon cytokine 
secretion and this tends to correlate with the expression of the TCR.  As 
demonstrated by Narayan et. al., the Vγ1.1+Vδ6.3- (V1), Vγ1.1+Vδ6.3+ (V6) and 
Vγ2+ (V2) population are three distinct subsets based upon high transcriptome 
analysis (49).  V1 and V6 cells predominantly secrete IFNγ and IL-4 while V2 
cells can secrete both IFNγ and IL-17 (50-52).  Aside from cytokine production, 
transcription factors are also associated with γδ T cell subsets based upon the 
types of cytokines that are secreted.  For example, IL-17 producing γδ T cells 
express the transcription factor Rorγt with most of the these cells belonging to the 
V2 subset (53).  Classification of the γδ T cell subsets based upon their TCR, 
cytokine profile and defining transcription factor is similar to how αβ T cell 
subsets are defined.  For example, αβ CD4+ T cells can differentiate into different 
T helper (TH) subsets depending on the infection.  Each subset is associated with 
a specific transcription factor and secretes specific cytokines.  For example TH1 
14
cells produce IFNγ, TH2 cells predominantly secrete IL-4 and IL-13 and TH17 
cells secrete IL-17 and IL-22.  Furthermore, differentiation of each subset is 
regulated by a specific transcription factor.  TH1 cells require T-bet, TH2 cells 
require GATA-3 and TH17 cells require Rorγt (54).  Upon differentiation of CD4+ T 
cells into TH cells, they can further the immune response by further activating 
other immune cells through the cytokines they secrete and cell-cell interactions. 
 For example, TH2 cells upon differentiation secrete IL-4 and IL-13, which 
can affect IgG1 and IgE B cell isotype switching in germinal centers (GC) (55).  
Within the GC, B cell isotype-switching, somatic hypermutation and affinity 
maturation occurs.  IgG1 and IgE are both considered T cell dependent B cell 
responses (56).  In order for IgG1 and IgE isotype-swtiching to occur, several 
molecules have been identified to be important such as CD40 and ICOS, where 
lack of signaling downstream of these molecules in CD4+ T cells result in 
defected GC formation (57).  In addition to cell-cell interactions, the cytokines IL-
4 and IL-13 are thought to enhance the gene transcription of the IgG1 and IgE 
constant regions (56, 58).  Recent studies have begun to further elucidate CD4+ 
T cell help for B cells and a new CD4+ T cell subset has begun to emerge called 
the T follicular helper  (TFH) (59).  The TFH cells express the chemokine receptor 
CXCR5, localize to the B cell follicles, highly express CD40 and ICOS (59-62).  It 
still remains unclear as to whether TH2 and TFH cells is more important in B cell 
class switching however, CD4+ T cells are thought to be the main cell type 
responsible for T cell dependent B cell responses. 
15
 Unlike αβ CD4+ T cells, each γδ T cell subset can be further subdivided 
based upon surface expression of other molecules.  V2 cells that migrate to the 
skin secrete IL-17.  Aside from the TCR receptor defining IL-17 secreting cells, 
they are also CD44+CD122- and express the chemokine receptor CCR6 and 
scavenger receptor SCART2 (63, 64).  In contrast, IFNγ secreting γδ T cells are 
not CCR6+, but instead express NK1.1 and CD122 (44, 64).  These data taken 
together demonstrates that even within specific Vγ subsets there is quite a bit of 
heterogeneity in selection and development.  Therefore, future studies can no 
longer examine γδ T cells as a single entity. 
 
Vγ1.1Vδ6.3 γδ T cell subset generation and function 
  
 The focus of this thesis will be on the V6 cell subset of γδ T cells.  
Originally defined as Thy1.1dull cells, V6 cells can simultaneously secrete IL-4 
and IFNγ and reside in the adult thymus, spleen and liver, though they are most 
abundant in the liver (65-69) and are not dependent upon MHC class I or II for 
development (65).  V6 cells express the activation marker CD44 and half the 
population expresses CD4 and NK1.1 (66).  These cells are rare in newborn 
mice and expand during the first 2 weeks of postnatal life before reaching 
homeostasis 3 weeks after birth (66).  Adult V6 cells have limited junctional 
sequence diversity within the Vδ6Cδ chains characterized by minimal to no N 
region diversity along with almost an invariable Dδ2-Jδ1 junction.  These features 
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are a characteristic of TCR rearrangements normally found in the fetal thymus 
(66, 67, 69, 70) due to the absence of terminal deoxytnucleotidyl transferase 
(TdT).  TdT adds N-nucleotides during TCR recombination and is not expressed 
until three to five days after birth (71-75).  Subsequent studies demonstrated that 
when adult bone marrow was grafted into lethally irradiated mice, the V6 
population did not fully develop.  In contrast, transplantation of fetal thymi into 
syngenic hosts resulted in V6 cell development suggesting that a majority of V6 
cells arise from fetal precursors (76).   
 Several molecules have been implicated in V6 cell development.  This 
includes the adaptor protein signaling lymphocyte activation molecule associated 
protein (SAP) a protein consisting of a single Src homology-2 domain and a short 
C-terminus.  SAP was first shown to play an important role in the immune system 
when mutations in SAP were found in cases of X-linked lymphoproliferative-1 
(XLP) diseases (77).  SAP is found down stream of signaling lymphocyte 
activation molecule (SLAM) receptors and binds to SLAM receptors through their 
immunoreceptor tyrosine based switch motif (ITSM), a signaling motif found in 
the cytoplasmic domain (77, 78).  SAP has recently been found to not only 
regulate positive signals through SLAM but also negative signals as well (77, 79).  
Lack of SAP has been shown to negatively affect V6 cells (80) thereby 
suggesting that SAP may modulate the development of V6 cells.   
 Another molecule important for V6 cells is the transcription factor PLZF 
(promyelocytic leukemia zinc finger, Zbtb16) a member of the BTB/POZ-ZF 
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(broad complex, trimtrack, bric-a-brac or poxvirus and zinc finger) family of 
transcription factors.  PLZF is defined by the presence of BTB-POZ and zinc 
finger domains, which was thought to be expressed exclusively in αβ iNKT and 
mucosal associated invariant T (MAIT) cells, an innate-like cell found in the gut 
lamina propria (80-83).  Although frequency, number and localization of V6 cells 
were not affected in PLZF-/- mice V6 cells were incapable of dual IL-4 and IFNγ 
secretion following stimulation (80, 83).  This data indicates that PLZF is required 
for the innate-like phenotype of V6 cells.  Another member of the BTB-POZ 
family member, ThPOK, was also found to be expressed in the V6 subset of γδ T 
cells (80, 84) and that as V6 cells mature, ThPOK expression increases.  Lack of 
ThPOK was shown to result in a decrease in V6 cells whereas overexpression of 
ThPOK resulted in an increase of V6 cells (84).  In addition, these studies 
showed that V6 cells highly expressing ThPOK were also PLZF+ and that in the 
absence of ThPOK, PLZF expression was reduced along with decreased IL-4 
secretion (80).  It is still unclear the exact role ThPOK has in V6 cells but it is 
possible that PLZF may have a role in regulating or modulating ThPOK. 
 Though lack of SAP, PLZF and ThPOK negatively affect V6 cells, lack of 
several other molecules has been shown to positively influence V6 cells.  
Inhibitor of DNA binding 3 (Id3) belongs to the extracellular signal related kinase 
(ERK), early growth response gene (Egr), Id3 signaling pathway and Id3 inhibits 
E protein activity during T cell development (85).  Several groups have shown 
that lack of Id3 results in the expansion of the V6 population thereby suggesting 
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that Id3 negatively regulates the development of V6 cells (86, 87) though the 
exact mechanism is unclear.  The role of these cells needs to be further 
elucidated but one study demonstrated that V6 transgenic mice on a RAG-/- 
background developed spontaneous dermatitis in the tail.  Closer examination of 
the tail in these mice showed massive infiltration by lymphocytes and 
granulocytes (83).  This suggests that the role of V6 cells may include the 
recruitment of other lymphocytes. 
 In recent years, the discovery that SAP and PLZF are required for the 
maturation and function of V6 cells have sparked interest in this T cell subset.  
Interestingly, the localization and function of V6 cells resembles another innate-
like lymphocyte, the αβ iNKT cells. 
 
αβ  iNKT cells 
  αβ iNKT cells are considered a classic example of an innate-like 
lymphocyte.  They constitute less than 1% of mouse T lymphocytes but promote 
cell-mediated immunity to bacterial and viral pathogenesis (88, 89).  αβ iNKT 
cells are primarily found in the thymus, spleen, bone marrow and liver where they 
preferentially home.  A small population of αβ iNKT cells can also be found in the 
lymph nodes and intestines.  The majority of mouse αβ iNKT cells express the 
invariant T cell receptor (TCR) Vα14-Jα18 with a limited Vβ pairing that are 
positively selected by CD1d recognizing lipid antigens (90).  In addition, SLAM 
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and its downstream adaptor molecule, SAP are required for αβ iNKT cell 
development, which is exemplified by the lack of SAP leading to a decrease in αβ 
iNKT cells (91, 92).  The transcription factor PLZF, a member of the BTB/POZ-ZF 
family of transcription factors, is required for αβ iNKT cell dual secretion IL-4 and 
IFNγ (81, 82).  PLZF also allows αβ iNKT cells to acquire a memory phenotype 
during development (93-97).  Based upon mouse studies, four stages of αβ iNKT 
cell development have been defined (Figure 1.3).    
 The earliest population of αβ iNKT cells to emerge are termed stage 0 and 
are defined by expression of CD24+ also known as heat stable antigen (HSA),  
CD44loNK1.1lo.  These cells all express CD4, are extremely rare and do not 
proliferate.  As CD24 is down regulated and cells enter stage 1 
(CD24loCD44loNK1.1lo), they enter a highly proliferative phase thereby expanding 
the NKT cell pool.  As αβ iNKT cells progress to stage 2 they become 
CD24loCD44hiNK1.1lo.  Stage 3 of αβ iNKT cell maturation includes the up-
regulation of NK cell receptors such as NK1.1 thereby becoming 
CD24loCD44hiNK1.1hi and is accompanied by much less proliferation (98, 99). 
Other markers can also be used to delineate the stages of αβ iNKT cell 
 maturation including the up regulation of the IL-2/IL-15 receptor β-chain (CD122) 
during stage 3 (93).  Along with surface markers defining the maturation stages 
of αβ iNKT cells, there are several other important changes in αβ iNKT cell 
function that accompany this transition.  Stage 1 and stage 2 αβ iNKT cells   
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1.3 αβ iNKT cell development and maturation 
αβ iNKT cells arise in the thymus from CD4+CD8+ double-positive (DP) 
thymocytes which have randomly rearranged their TCR.  Thymocytes that are 
selected by CD1d bound to self-glycolipid expressed by other DP thymocytes 
become αβ iNKT precursors.  αβ iNKT cell precursors undergo further 
differentiation characterized by the expression of cell surface markers (CD24, 
CD44, CD4, CD122 and NK1.1), changes in transcription factor (PLZF) 
expression and functional potential (IL-4 and IFNγ).
21
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acquire the ability to secrete IL-4 and make little IFNγ, whereas stage 3 αβ iNKT 
cells produce abundant IFNγ but little IL-4 (100, 101).  Stages 0, 1 and 2 are 
thought to be thymus dependent but most αβ iNKT cells emigrate from the 
thymus before stage 3 and maturation continues out in the periphery (102, 103).   
 Thus far the development and function of V6 and αβ iNKT cells, two 
different innate-like lymphocyte populations, have been described.  To better 
understand the molecular mechanisms of V6 cells, the T cell signaling pathway in 
γδ T cells should be further examined. 
 
TCR signaling 
 
 Activation of the αβ T cell receptor (TCR) is initiated after TCR interaction 
with peptide-MHC complexes on antigen presenting cells (APC), leading to a 
cascade of signaling events.  Following TCR stimulation, the Src-family kinase 
Lck is activated leading to the phosphorylation of immunoreceptor tyrosine 
activation motifs (ITAMs) on the intracellular domains of CD3 resulting in the 
recruitment of ZAP-70.  ZAP-70 binds to the phosphorylated ITAMS and is 
phosphorylated by Lck, which goes on to phosphorylate the adaptors linker for 
activation of T cells (LAT) and SH2-domain-containing leukocyte protein of 76 
kDa (SLP-76) (104-108).  Activation and recruitment of the Tec family kinase Itk, 
to the membrane through its pleckstrin homology (PH) domain occurs following 
phosphoinositide-3-kinase (PI3K) activation and accumulation of 
23
phosphatidylinositol (3,4,5) triphosphate (PIP3) in the plasma membrane (109-
111).  Phosphorylated LAT and SLP-76 serves as a platform for recruitment of Itk 
through Itk’s Src homology (SH)-3 and SH2 domains (112-118) allowing for Lck 
phosphorylation of Itk on its activation loop (Y511) (119).  Upon activation and 
recruitment of Itk to the membrane, Itk phosphorylates and activates 
phospholipase Cγ1 (PLCγ1)(19, 21) which hydrolyzes phosphatidylinositol 4,5-
bisphosphate (PI(4,5)P2) into inositol-1,4,5-triphosphate (IP3) and diacylglycerol 
(DAG) (120).  Following cleavage of PI(4,5)P2, DAG activates members of the 
protein kinase C (PKC) family and Ras-GRP which leads to the activation of JUN 
amino-terminal kinase (JNK) and ERK1/2 thereby regulating the transcription 
factor activator protein-1 (AP-1) (121-124).  In addition, ERK can also go on to 
activate the Id3 (125).  IP3 enables intracellular Ca2+ release and sustained 
calcium influx results in activation of downstream effectors including nuclear 
factor of activated T cells (NFAT) transcription factor (126, 127). TCR signaling 
results in transcription activation (126), cytokine release (128, 129) and actin 
reorganization (130) (Figure 1.4)   
 Deletion of the proximal components of TCR signaling such as Itk, have 
defects downstream of the TCR.  Itk-/- T cells exhibit reduced but not absent  
responses to TCR stimulation.  This includes defects in PLCγ phosphorylation, 
IP3 production, Ca2+ influx, ERK and JNK activation along with decreased 
downstream activation of transcription factors, NFAT and AP1, and decreased 
cytokine production (121, 123, 129, 131, 132).  This indicates that Itk plays an 
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Figure 1.4 T cell receptor signaling 
Stimulation through the T cell receptor results in the recruitment and activation of 
both Lck and ZAP-70.  Lck and ZAP-70 phosphorylates and activates Slp-76 and 
LAT resulting in the formation of a signaling complex which recruits Itk.  Lck 
phosphorylates and activates Itk where Itk goes on to phosphorylate PLCγ.  
Activated PLCγ catalyzes PIP2 to IP3 and DAG.  IP3 induces Ca2+ mobilization 
and DAG induces mitogen-associated protein kinase (MAPK) activation resulting 
in the transcription of nuclear factor for activated T cells (NFAT) and activator 
protein-1 (AP-1), respectively. 
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important role in αβ TCR signaling. 
 
Tec family kinases 
 
 The Tec family kinases are a small group of nonreceptor tyrosine kinases 
consisting of Tec, Btk, Itk/Emt/Tsk, Rlk/Txk and Bmx/Etk.  These kinases are 
primarily found in hematopoieic cells, including B cells (133-136), T cells (133, 
137-141) and mast cells (142-144), although Tec and Bmx are also found in 
endothelial cells.  Each cell subset may express more than one Tec kinase but 
may favor the use of one Tec kinase over the other.  For example even though T 
cells can express Itk, Rlk and Tec, Itk is predominantly expressed.   Similar to 
Src family tyrosine kinases, Tec kinases are comprised of an SH2 domain which 
recognizes phosphorylated tyrosines, an SH3 domain that binds proline rich 
motifs, and a C-terminal kinase domain that transfers phosphates onto tyrosine 
residues on substrate proteins (145).  Unlike Src kinases, at the amino-terminal 
side of the SH3 domain, the Tec family kinase members, with the exception of 
Bmx, have a proline rich region (PRR).  Within the amino-terminal end of the 
PRR in Itk, Btk and Tec, there is also a Zn2+-binding region called the Btk 
homology (BH) motif.  The Tec homology (TH) domain consists of both the BH 
domain and the PRR.  With the exception of Rlk, all the Tec family kinases 
contain a pleckstrin homology (PH) domain that binds to phosphatidylinositol 
ligands in cell membranes.  Rlk contains a cysteine-string motif at the amino-
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terminal region allowing Rlk to be constitutively localized at the cell membrane 
(Figure 1.5) (146) . 
 
Tec Family Kinase, Itk 
 
 Tec kinases were first found to be relevant in humans in 1993 when 
mutations in Btk were found to play a role in immunodeficiences such as human 
B-cell immunodeficiency, X-linked agammaglobulinemia (XLA) and the murine 
mutant X-linked immunodeficiency (xid) (134-136, 147).  The importance of Tec 
kinases in lymphocytes and antigen receptor signaling in humans was 
emphasized by XLA being the first example of a mutation in a tyrosine kinase 
found in a human immunodeficiency.  In T cells, Itk, Rlk and Tec are the three 
Tec family kinases expressed with Itk having the predominant role in TCR 
signaling.  Itk is expressed in mature T cells, mast cells and αβ iNKT cells, with 
the maximal level of expression found in the mature adult thymus.  These studies 
demonstrate that upon TCR stimulation and treatment with IL-2, Itk is induced 
(138, 140, 141, 148, 149) while Rlk mRNA and protein levels are reduced upon 
activation (139, 144).  In addition, in mature resting T cells Rlk mRNA levels are  
already 3-10 fold lower compared to Itk mRNA levels (139, 144, 150, 151).  
Furthermore, Itk levels are up regulated 2-3 fold in TH2 cells compared to TH1 
cells during naïve CD4+ T cell helper differentiation (150, 151).  These data  
suggests that Itk is the predominant Tec kinase in T cells and plays an important 
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Figure 1.5 Organization of the Tec family kinase domains 
Tec family kinases are structurally similar to Src family kinases.  Tec kinases 
include a catalytic C terminal kinase domain, followed by two Src homology (SH2 
and SH3) domains.  Btk and Tec contain 2 PRR regions, while Itk and Rlk only 
contain one.  All Tec family kinases have a Btk homology domain (BH) or a N-
terminal pleckstrin homology region (PH), except Rlk.  Instead Rlk has N-terminal 
cysteine repeats. 
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role in T cell differentiation. 
 Until recently, mutations in Itk were not shown to be associated with 
diseases in humans.  Itk was first associated with human diseases during 
examination of two patients who died after developing fatal Epstein Barr virus 
(EBV)-associated lymphoproliferative disorder.  This disorder clinically resembled 
XLP, and the patients were found with homozygous missense mutations in the 
SH2 domain of Itk.  This mutation in Itk led to protein destabilization, lack of Itk in 
lymph node biopsies along with an absence of NKT cells (152).   Additional 
studies in patients with EBV-driven lymphoproliferative disease uncovered a 
range of mutations in Itk including missense, nonsense and indel mutations 
resulting in varying degrees of loss of function in Itk (153).  In addition to loss of 
function mutations, altered expression of Itk has been found in pathological 
states such as atopic dermatitis.  Analysis of genes in patients with atopic 
dermatitis, a TH2-mediated disease, revealed elevated Itk expression in T cells 
(154).  These studies indicate that Itk contributes to human diseases affecting T 
cell activation and cytokine production. 
 
Itk regulation of T cell function 
 
 Itk deficiency in TCR signaling lead to defects in activation of downstream 
signaling components, such as PLCγ.  Therefore, it was interesting that T cells 
were still able to develop in Itk-/- mice.  However, differentiation of T cells, 
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including CD4+ αβ T cells, was altered.  Numerous studies have addressed T cell 
function in vivo during pathogen infections and found that lack of Itk affects TH2 
responses.  The first study to demonstrate Itk’s importance in TH2 cells was 
performed in Itk-/- Balb/c mice. Infection with Leishmania major in Itk-/- Balb/c 
mice, which normally elicits a TH2 response, showed that Itk-/- Balb/c mice were 
unable to mount a TH2 response compared to wild type mice.  Instead Itk-/- Balb/c 
mice generated a protective TH1 response (131).  Defects in TH2 responses In 
Itk-/- mice were further confirmed with in vivo infections with Nippostrongylus 
brasiliensis (131) and Schistosoma mansoni (132).  These two parasitic 
infections are normally eliminated by TH2-dependent recruitment and activation 
of granulocytes, but closer analysis of cytokine responses of the parasite-specific 
T cells in Itk-/- mice revealed decreased IL-4, IL-5, IL-10 and IL-13 production 
(132).  In vitro experiments with CD4+ T cells from Itk-/- mice also demonstrated 
reduced levels of TH2 cytokines under TH2 polarizing conditions compared to wild 
type CD4+ T cells further confirming the in vivo experiments (131, 132, 151).  
These experiments establish that in Itk-/- mice TH2 cells are defective in IL-4 and 
IL-13 production and as mentioned previously, these cytokines are required for 
IgE class switching by B cells which can go on to further activate mast cells to 
release histamine (3) leading to allergies.  Therefore, it is interesting that Itk-/- 
mice have elevated IgE levels in the serum (155). 
 In addition to the requirement for Itk in effector cytokine production for 
CD4+ TH2 cells, Itk is also required for αβ iNKT cell maturation and effector 
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cytokine production.  Studies by numerous labs have shown that Itk-/- mice 
exhibit a reduction in the number of αβ iNKT cells.  Furthermore, the remaining 
αβ iNKT cells display an immature phenotype, show poor response to TCR 
stimulation and produced little to no IL-4 and IFNγ following in vivo activation 
(156-158).  Given the importance of Itk in the generation of TH2 cytokines such 
as IL-4 and IL-13, Itk has become an attractive target for anti-asthmatic and 
allergy drugs.  Yet, human studies have demonstrated that further research 
needs to be done to understand the effect of Itk in cells other then TH2 cells.  The 
experiments that follow in this thesis further examine the role of Itk on the innate 
like population γδ T cells. 
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Introduction 
The Tec family tyrosine kinase Itk is important for signaling downstream of 
the T cell receptor (146).  In particular, Itk-deficient T cells have defects in PLC-
γ phosphorylation, calcium mobilization, MAP kinase activation, and AP-1 and 
NFAT activation following TCR stimulation.  Itk is also critical for conventional αβ 
T cell development, selection, and function.  Of particular importance, Itk 
signaling regulates CD4+ T helper cell differentiation, playing a key role in the 
development of TH2 responses (159).  Based on this well-documented defect of 
Itk-/- mice in generating TH2 effector responses and cytokine production, it was 
surprising to discover that these mice had spontaneously-elevated levels of 
serum IgE (4, 132), as B cell isotype switching to IgE is highly dependent on TH2 
cytokines IL-4 and IL-13 (2).  As our previous studies had indicated that Itk-/- αβ 
TCR+ NKT cells (referred to as αβ NKT cells) were also highly defective in 
producing effector cytokines such as IL-4 (158), we considered the possibility 
that γδ TCR+ NKT cells were the major source of TH2 cytokines in Itk-/- mice.    
γδ T cells are a highly conserved subset of T cells that constitutes 1-5% of 
the lymphocytes in the blood and peripheral organs of mice, but can account for 
up to 50% of the lymphocytes in the mucosal epithelia.  As with other subsets of 
‘innate’ T cells, γδ T cells express memory cell surface markers (160), and are 
capable of rapidly secreting effector cytokines (34).  Among the many functions 
attributed to γδ T cells, a great deal of recent interest has focused on their ability 
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to modulate adaptive immune responses, specifically the humoral response 
(161). 
A variety of studies have indicated that γδ T cells are able to provide help 
for B cell responses.  Initial studies performed in mice lacking αβ T cells showed 
that B cell expansion, differentiation, and secretion of ‘T-dependent’ antibody 
isotypes, IgE and IgG1, were all intact in these mice (7).  Further, TCRβ-/- mice, 
challenged repeatedly with parasitic infections, could produce germinal centers 
and generate increased antibody production (6).  Utilizing a model of pulmonary 
allergic inflammation, decreased production of IgE and IgG1 was seen in mice 
lacking γδ T cells compared to wild type mice (162).  γδ T cells have also been 
shown to directly induce germinal center formation and Ig hypermutation (163).  
Interestingly, even though the γδ T cells expressing CD4 account for only 5-10% 
of all γδ cells, it is this subset that appears to be responsible for inducing germinal 
centers (164).  Human γδ T cells have also been found in germinal centers; these 
cells were found to up-regulate B-cell costimulatory molecules such as CD40L, 
OX40, CD70, and ICOS in response to TCR stimulation (10, 165).  Together, 
these data indicate that γδ T cells can promote, either directly or indirectly, the 
humoral immune response. 
Here we show that, in the absence of Itk, γδ T cell differentiation and 
effector function are dramatically altered.  Itk-/- mice contain increased numbers 
of CD4+ and NK1.1+ γδ T cells that normally constitute the γδ NKT population 
37
(166).  These cells express PLZF, a transcription factor that uniquely defines αβ 
NKT cells and is essential for normal αβ NKT cell development (81, 82).   As a 
consequence, Itk-/- γδ T cells produce robust amounts of TH2 cytokines when 
stimulated, accompanied by enhanced expression of cell surface receptors 
associated with B cell help, such as ICOS and CD40L, and thus, promote a 
spontaneous elevation in serum IgE levels.  These data indicate a surprising role 
for Itk in regulating the lineage development and effector function of γδ T cells, 
particularly in controlling the PLZF+ subset.   
 
Results 
γδ T cells promote the hyper IgE and enriched GC phenotype seen in Itk-/- mice 
In an effort to identify the cell type producing Th2 cytokines and driving 
IgE class-switching and secretion in unimmunized Itk-/- mice, we considered γδ T 
cells.  To test this possibility, Itk-/- mice were crossed to Tcrd-/- mice (167) that 
lack γδ T cells.  As shown in Figure 2.1A and reported previously (4, 132), Itk-/- 
mice have elevated concentrations of serum IgE compared to wild type controls.  
Strikingly, in Itk/Tcrd-/- double-deficient mice, serum IgE levels drop significantly 
compared to Itk-/- mice.  Similar results were seen upon analysis of the proportion 
of germinal center phenotype B cells (B220+PNA+) (Figure 2.1B).  Individual 
cohorts of mice were tested at 2 months of age, 3.5 months of age, and 5 months 
of age, with similar results (Figure 2.2 A and B). 
 
38
Figure 2.1.  γδ  T cells in Itk-/- mice are responsible for the spontaneous 
elevation in serum IgE levels.   
(A) Serum obtained from wild type, Tcrd-/-, Itk-/-, and Itk-/-Tcrd-/- mice were 
analyzed for IgE by ELISA.  (B) Splenocytes from wild type, Tcrd-/-, Itk-/-, and Itk-/-
Tcrd-/- mice were stained with α-B220 Ab and PNA to identify germinal center B 
cells.  Differences between wild type and Tcrd-/- (p=0.14) and between Itk-/- and 
Tcrd-/- (p=0.54) were not statistically significant.  (C) Cells were prepared from 
thymus, spleen, mesenteric lymph nodes (mLN), intestinal epithelium (iIELs), and 
liver and were stained with anti-TCRδ and anti-TCRβ Abs.  (D-F) Percentages 
and absolute numbers of γδ T cells were compiled for the thymus (D) and spleen 
(E); percentages only were compiled for liver (F).  
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Figure 2.2.  Hyper IgE syndrome can be seen in Itk-/- mice as early as 2.5 
months.   
(A) Serum obtained from 2.5, 3 and 5 month old wild type, Tcrd-/-, Itk-/-, and Itk-/-
Tcrd-/- mice were analyzed for IgE by ELISA.  (B) Splenocytes from 2.5, 3 and 5 
month old wild type, Tcrd-/-, Itk-/-, and Itk-/-Tcrd-/- mice were stained with α-B220 
Ab and PNA to identify germinal center B cells.   
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Itk-deficient mice have increased numbers of γδ T cells 
The finding that elevated serum IgE levels in Itk-/- mice were dependent on 
γδ T cells suggested that the γδ T cells present in Itk-/- mice might be altered 
relative to their wild type counterparts.  We first examined γδ T cell numbers.  As 
seen in Figure 2.1C, Itk-/- mice have increased proportions of γδ T cells in the 
thymus, the spleen, the mesenteric lymph nodes, and the liver, but not in the 
intestinal intraepithelial lymphocyte (iIEL) compartment.  A summary of data 
indicates significant increases in the proportion and absolute numbers of γδ T 
cells in both the thymus and the spleen, as well as an increase in the percentage 
of γδ T cells in the liver, in the absence of Itk (Figure 2.1D-F).   
 
Itk-/- mice contain increased proportions of γδ T cells subsets expressing 
Vγ1.1+Vδ6.3+, CD4 and NK1.1 
 Analysis of TCRγ chain repertoires indicated an increased proportion in 
Vγ1.1+ γδ T cells in Itk-deficient versus wild type mice, and a concomitant 
decrease in the other major subsets (Vγ2+ and Vγ5+) (Figure 2.3A, B).  Further, 
the majority of Vγ1.1+ γδ T cells in the thymus and liver of Itk-/- mice also 
expressed Vδ6.3 (Figure 2.3C).  Overall, we find a significant increase in the 
absolute numbers of this γδ T cell subset in thymus and spleen of Itk-/- mice 
compared to controls (Figure 2.3D, E), as well as an increased proportion of 
Vγ1.1+Vδ6.3+ γδ T cells in Itk-/- liver (Figure 2.3F).   Interestingly, Vγ1.1+Vδ6.3+  
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Figure 2.3.  Itk-/- mice have an increased population of Vγ1.1Vδ6.3+ γδ  T 
cells.   
(A) Thymocytes and splenocytes were stained with antibodies to TCRδ and 
either Vγ1.1, Vγ2, Vγ3, and Vγ5.  Histograms show Vγ staining on gated TCRδ+ 
cells.  (B) Lymphocytes were isolated from the liver and stained with antibodies 
to TCRδ and Vγ1.1 or Vγ2.  Histograms show Vγ staining on gated TCRδ+ cells.  
(C) Thymocytes, splenocytes, and liver cells were stained with antibodies to 
TCRδ, Vγ1.1 and Vδ6.3.  Dot plots show Vγ1.1 versus Vδ6.3 staining on gated 
TCRδ+ T cells.  (D) Absolute numbers of Vγ1.1Vδ6.3+ γδ T cells in the thymus and 
spleen, and percentages of Vγ1.1Vδ6.3+ γδ T cells in the liver were compiled.  
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γδ T cells are the predominant subset of γδ NKT cells, and readily produce 
effector cytokines (66, 166, 168). 
In contrast to wild type γδ T cells, the Itk-/- γδ T cell population showed a 
striking increase in the proportion of CD4+ cells in the thymus, spleen and liver 
(Figure 2.4A, B).  Itk-/- mice also had elevated proportions of thymic NK1.1+ γδ T 
cells (Figure 2.4C, D).  Interestingly, the majority of the thymic Itk-/- CD4+ γδ T 
cells and virtually all of the thymic Itk-/- NK1.1+ γδ T cells express high levels of 
the memory cell marker CD44 (Figure 2.4E), as well as the activation marker 
CD69.  As previously reported, the majority of γδ T cells in the liver of wild type 
mice are NK1.1+ (i.e., γδ NKT cells) (166), and this is also the case in Itk-/- liver 
(Figure 2.4C, D).  
Focusing on the Vγ1.1+Vδ6.3+ subset of γδ T cells, we find that wild type 
and Itk-/- mice each have a similar proportion of NK1.1+ CD4- cells, whereas 
NK1.1+ CD4+ cells are increased substantially in Itk-/- mice (Figure 2.5).  
Furthermore, outside the thymus, the Vγ1.1+Vδ6.3+ subset is found 
predominantly in the liver, rather than the spleen (Figure 2.4F, G), as has been 
reported previously for γδ NKT cells (166).  The γδ T cells not expressing 
Vγ1.1Vδ6.3 correspond to the “conventional” NK1.1-CD4-CD8- subset; this 
conventional γδ T cell subset is not altered in numbers in Itk-/- versus wild type 
mice, indicating that Itk controls the generation of “nonconventional” CD4+ or 
NK1.1+, but not conventional, γδ T cells. 
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Figure 2.4.  Altered γδ  T cell subsets in the spleen and thymus of Itk-/- mice.   
Cells were prepared from thymus, spleen, and liver of wild type and Itk-/- mice 
and analyzed by flow cytometry.  (A) CD4 versus CD8 expression on gated 
TCRδ+TCRβ- cells.  The percentages of each subpopulation are indicated, and 
the mean fluorescence intensities are shown in parentheses.  (B) The 
percentages of CD4+TCRδ+ cells in the thymus, spleen, and liver are shown.  (C) 
CD4 versus NK1.1 expression on gated TCRδ+TCRβ- cells in the thymus, spleen, 
and liver. (D) The percentages of NK1.1+TCRδ+ cells in the thymus, spleen, and 
liver.  (E) Thymic TCRδ+TCRβ- cells were analyzed for CD44 versus CD4 (top) or 
NK1.1 (bottom) expression.  Data are representative of 2 independent 
experiments.  (F) TCRδ+TCRβ- cells from the liver were analyzed for Vγ1.1, 
Vδ6.3, NK1.1, and CD4 expression.  Dot-plots show NK1.1 versus CD4 
expression on gated Vγ1.1+Vδ6.3+ cells.  (G) The percentages of total cells in the 
thymus, spleen, and liver that represent the Vγ1.1+Vδ6.3+NK1.1+ subset were 
calculated.  Differences between the wild type and Itk-/- were statistically 
significant (thymus, p=0.0006; spleen, p=0.0006; liver, p=0.001).  
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Figure 2.5 Enhanced population of CD4+ NK1.1+ Vγ1.1+ Vδ6.3+ γδ  T cells in 
Itk-/- mice.  
Thymocytes (A) and splenocytes (B) were isolated from wild type and Itk-/- mice 
and were stained with antibodies to TCRδ, CD4, NK1.1, Vγ1.1, and Vδ6.3. TCRγδ 
T cells were analyzed for Vγ1.1 vs. Vδ6.3 staining. Each of the four 
subpopulations was then examined for CD4 vs. NK1.1 staining, as shown. 
Numbers on dot-plots indicate the percentage of cells in the quadrant. Data are 
representative of two independent experiments with three mice per group. 
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Expanded populations of CD4+ γδ T cells have been previously 
demonstrated in mice lacking expression of both TCRβ and CD5 (164).  We 
therefore examined CD5 expression on Itk-/- γδ T cells, to determine if altered 
levels of CD5 might be contributing to the increased number of CD4+ γδ T cells in 
these mice, but detected no differences between wild type and Itk-/- mice (Figure 
2.6A).  However, like a previously-reported subset of activated γδ T cells specific 
for self-ligands, the MHC class Ib molecules, T10/T22 (23), the NK1.1+ subset of 
thymic Itk-/- γδ T cells are all CD122-positive (Figure 2.6B). 
 To determine whether the alterations we observed in Itk-/- mice are 
intrinsic to the hematopoietic cells or to the environment, we generated bone  
marrow chimeras using wild type or Itk-/- bone marrow cells.  These experiments 
demonstrated that the increased proportions of both γδ T cells and germinal 
center B cells seen in Itk-/- mice are intrinsic to Itk-/- hematopoietic cells (Figure 
2.7).  Consistent with these data, we also find that the predominant Tec kinase 
expressed in wild type γδ T cells is Itk (Figure 2.8A).  
 
Enhanced expression of IL-4 and PLZF in Itk-deficient γδ T cells 
To determine the basis for the altered function of Itk-/- γδ T cells, we 
examined mRNA levels for T-bet, Eomesodermin, and GATA-3 in wild type 
versus Itk-/- γδ T cells.  We found that Itk-/- γδ T cells consistently expressed 
higher levels of GATA-3 mRNA and protein compared to wild type γδ T cells,  
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Figure 2.6: Itk-/- γδ  T cells express CD5 and CD122 
Cells were prepared from thymi and/or spleens of wild type and itk-/- mice, 
stained and gated on TCRγ+TCRβ- cells.  (A) Splenic TCRγ+TCRβ- cells were 
analyzed for CD5 and CD4 expression [top panel] and CD5 and NK1.1 
expression [bottom panel].  (B) Thymic TCRγ+TCRβ- cells were analyzed for 
CD122 and NK1.1 expression.  Data is representative of 2 independent 
experiments with 3 mice per group. 
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Figure 2.7 The γδ  T cell phenotype in Itk-/- mice is intrinsic to the 
hematopoietic cells.  
Thymocytes (A) and splenocytes (B) were isolated from wild type, Itk-/- and wild 
typeè wild type and Itk-/-è wild type chimeric mice, and were analyzed by flow 
cytometry for γδ T cells. γδ T cells were further examined for expression of CD4, 
CD8, NK1.1, and CD44. Numbers on dot-plots indicate the percentage of cells in 
the quadrant. Data are representative of four mice per group. 
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Figure 2.8 Expression of Tec kinases and transcription factors in γδ  T cells. 
(A) Pooled splenocytes and lymph node cells were isolated from WT mice and 
total γδ T cells, NK1.1- and NK1.1+ γδ T cells subsets were isolated by cell 
sorting, and RNA was prepared. Peripheral CD8+ αβ T cells were analyzed for 
comparison. Levels of Itk (left panel), Rlk (middle panel), and Tec (right panel) 
mRNA were determined by real-time quantitative RT-PCR. Graphs show data 
normalized to β-actin mRNA levels in each sample and are representative of two 
independent experiments. (B) NK1.1- (left panel) and NK1.1+ (right panel) γδ T 
cells were isolated from spleens of wild type and Itk-/- mice, and RNA was 
prepared. Levels of T-bet, eomesodermin, and GATA-3 mRNA were determined 
by real-time quantitative RT-PCR. Graphs show data normalized to β-actin 
mRNA levels in each sample and are representative of two independent 
experiments. (C) γδ T cells were isolated from spleens of wild type and Itk-/- mice, 
and protein lysates were analyzed for T-bet and GATA-3 levels by Western blot 
analysis. As controls, CD4+ αβ T cells were isolated, protein lysates were 
prepared from unstimulated cells, and cells cultured in vitro for 7 days in TH1 or 
TH2 polarizing conditions. Levels of HSP70 are shown as a loading control. 
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while the NK1.1- subset of Itk-/- γδ T cells have reduced levels of mRNA for both 
T-bet and Eomesodermin (Figure 2.8B, C).  These findings suggested that Itk-/- γδ 
T cells might produce a distinct pattern of cytokines compared to wild type γδ T 
cells.  We first examined mRNA levels for the signature cytokines, IL-4 and IFNγ, 
following γδ T cell activation in vitro.   As shown in Figure 2.9A, in response to γδ 
TCR stimulation, Itk-/- γδ T cells have constitutively elevated levels of IL-4 mRNA 
prior to stimulation, and show dramatically enhanced induction of IL-4 mRNA at 
10h and 20h post-stimulation compared to wild type γδ T cells.  Basal levels of 
IFNγ mRNA were similar between the wild type and Itk-/- γδ T cells, and following 
stimulation, both cell types produced IFNγ, although wild type γδ T cells show 
higher levels of IFNγ mRNA compared to γδ T cells lacking Itk. 
  Based on the high proportion of Vγ1.1+Vδ6.3+ γδ T cells present in Itk-/- 
mice, and the previous association of this γδ T cell subset with dual production of 
IL-4 and IFNγ (66, 168), we also examined wild type and Itk-/- γδ T cells for 
expression of the transcription factor PLZF.  PLZF has recently been found to be 
critical for the development and effector function of TCRαβ+ NKT cells, where it 
promotes the simultaneous production of IL-4 and IFNγ (81, 82).  Interestingly, 
we found that splenic Itk-/- γδ T cells express substantially higher amounts of 
PLZF mRNA than do WT γδ T cells (Figure 2.9B).  Furthermore, among Itk-/- γδ T 
cells, the NK1.1+ fraction expresses particularly high levels of PLZF mRNA 
(Figure 2.10).  
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Figure 2.9.  Itk-/- γδ  T cells produce IL-4 plus IFN-γ  and express the 
transcription factor PLZF.   
Lymph nodes and spleens from wild type and Itk-/- mice were pooled and total 
TCRγδ+ cells (A-B) or sorted subpopulations (C-D) were analyzed.  (A)  2 x 105 
cells were stimulated with 10 µg/ml of anti-TCRδ for 0, 10 and 20 hours.  IL-4 (left 
panel) and IFNγ (right panel) mRNA expression levels normalized to β-actin were 
determined by real-time quantitative RT-PCR.  Data shown are representative of 
two independent experiments.  (B) Levels of PLZF mRNA normalized to β-actin 
were determined by real-time quantitative RT-PCR. WT peripheral CD8+ αβ T 
cells and αβ NKT cells were analyzed for comparison.  Data are representative of 
two independent experiments.  (C) 5x104 cells were stimulated with 10 µg/ml of 
anti-TCRδ for 72 hours and supernatants were analyzed for the presence of IL-4, 
IL-10, IL-13, and IFNγ by cytometric bead array (CBA).  Data are representative 
of three independent experiments.  (D) 3x104 cells were stimulated as in C.  
Supernatants were analyzed for the presence of IL-4, IL-10, IL-13, and IFNγ by 
CBA.  Data are representative of two independent experiments.  (E) 
Unstimulated (NS) and stimulated (P/I) wild type (left) and Itk-/- (right) γδ T cells 
were analyzed for intracellular IL-4 and IFN-γ production.  Cells were stimulated 
with 10 ng/ml PMA and 2 µg/ml Ionomycin (P/I) for 4 hours.  Data are 
representative of four independent experiments. 
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Figure 2.10.  Itk-/- NK1.1+ γδ  T cells express elevated levels of the 
transcription factor PLZF. 
Lymph nodes and spleens from wild type and Itk-/- mice were pooled and total 
TCRγδ+ cells and sorted subpopulations were analyzed for PLZF expression.  
PLZF mRNA expression was determined by real-time quantitative RT-PCR and 
normalized to β-actin. 
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These findings support for the conclusion that γδ T cell development is altered in 
the absence of Itk.  
To assess levels of cytokine protein secretion, individual subsets of Itk-/- 
and wild type γδ T cells were purified and stimulated.  As previous studies have 
found that NK1.1+ γδ T cells and CD4+ γδ T cells produce the highest levels of 
cytokines, particularly ‘TH2’ cytokines (65, 169-172), we compared NK1.1+ to 
NK1.1-, and CD4+ to CD4- γδ T cell subsets.  After 72h of stimulation, wild type 
NK1.1+ γδ T cells secreted more IL-4, IL-10, and IL-13 than their NK1.1- 
counterparts; in contrast, both NK1.1+ and NK1.1- subsets of wild type γδ T cells 
secreted large amounts of IFNγ (Figure 2.9C).  Consistent with the analysis of 
cytokine mRNA levels, we observed elevated secretion of the TH2 cytokines IL-4, 
IL-10, and IL-13 by the Itk-/- NK1.1+ γδ T cells when compared to WT NK1.1+ 
cells; furthermore Itk-/- NK1.1+ γδ T cells secreted much higher amounts of these 
cytokines per cell relative to the Itk-/- NK1.1- subset.  In addition, we found that 
both subsets of Itk-/- γδ T cells secreted IFNγ, but at a lower level than the wild 
type cells.   
Comparison of the CD4+ versus CD4- subsets of γδ T cells confirmed 
previous data (171, 172) that γδ T cells expressing CD4 are the major cytokine 
producing population, particularly for the ‘TH2’ cytokines.  As shown in Figure 
2.9D, Itk-/- CD4+ γδ T cells produce elevated levels of IL-4 and IL-13 compared to 
wild type CD4+ γδ T cells, but similar levels of IL-10.  None of these cytokines 
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were detected in supernatants of stimulated CD4- γδ T cells from either Itk-/- or 
wild type mice.  As noted above, wild type γδ T cells (both CD4+ and CD4- 
subsets) secrete higher levels of INFγ than Itk-/- γδ T cells.  
 On a population basis, Itk-/- γδ T cells secreted both IL-4 and IFNγ 
following stimulation.  To determine whether individual cells were dual producers 
of both effector cytokines, we stimulated wild type and Itk-/- γδ T cells in vitro with 
PMA and ionomycin and then examined IL-4 and IFNγ production by intracellular 
cytokine staining (Figure 2.9E).  As expected, a larger proportion of wild type γδ T 
cells produce IFNγ in response to stimulation compared to those that produce IL-
4, and few cells produce both cytokines.  In contrast, Itk-/- γδ T cells include a 
significantly larger population that produces IL-4 than is seen in the wild type γδ T 
cell subset (Itk-/-, 6.9±1.1; wild type, 3.5±0.8; n=7; p=0.04); additionally, a greater 
proportion of Itk-/- γδ T cells produces both IL-4 plus IFNγ compared to wild type 
γδ T cells (Itk-/-, 3.9±0.8; wild type, 1.7±0.3; n=7; p=0.02).  Since this 
pharmacological stimulation bypasses the need for Itk in TCR-mediated 
signaling, these data indicate that a larger proportion of Itk-/- γδ T cells are 
programmed to produce IL-4, as well as IL-4 plus IFNγ, prior to their activation.  
This latter finding, together with the data demonstrating increased numbers of 
CD4+ and NK1.1+ γδ T cells in the Itk-/- mice, strongly suggest that γδ T cell 
development is altered in the absence of Itk leading to a striking increase in a 
PLZF-positive, IL-4-producing γδ T cell population.  
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Itk-/- γδ T cells up-regulate surface receptors that promote B cell help 
We next examined γδ T cells for the expression of co-stimulatory 
molecules that provide B cell help, such as CD40L, CD70, OX40, and ICOS (10).  
For these experiments, wild type and Itk-/- thymocytes and splenocytes were 
evaluated directly ex vivo, and in addition, were cultured for 24h in the presence 
of stimulatory anti-TCRδ antibodies.  While analysis of splenic γδ T cells from wild 
type and Itk-/- mice did not reveal any major changes in co-stimulatory markers, 
we did see a small increase in the proportion of constitutively ICOS-positive γδ T 
cells in the spleens of Itk-/- mice.  Since Itk-/- mice have a two-fold increase in the 
absolute number of total γδ T cells in the spleen compared to wild type, this 
difference amounts to a ~10-fold increase in ICOS-positive splenic γδ T cells, and 
thus could account for the enhanced B cell activation observed in Itk-/- mice. 
More strikingly, levels of ICOS were increased on a large proportion of the 
thymic Itk-/- γδ T cells compared to controls, but remained unaltered following 
stimulation (Figure 2.11A).  Evaluation of the ICOShi fraction of Itk-/- thymic γδ T 
cells indicated that nearly all of these cells were CD4+, and a substantial 
proportion were also NK1.1+ (Figure 2.11B).  Little to no difference was seen in 
the basal levels of CD40L and OX40 when comparing thymic Itk-/- γδ T cells to 
wild type γδ T cells directly ex vivo (Figure 2.11A).  However, after 24h of in vitro  
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Figure 2.11.  Itk-/- γδ  T cells up-regulate costimulatory molecules involved in 
B cell help.   
(A) Thymocytes from wild type and Itk-/- mice were pooled, and left unstimulated 
(0 hrs) or were stimulated with 10 µg/ml α-TCRδ for 24 hours.  Unstimulated and 
stimulated TCRδ+TCRβ- T cells were then analyzed for the expression of ICOS, 
CD40L, and OX40.  (B) Wild type and Itk-/- thymocytes stimulated for 24 hours 
with 10 µg/ml α-TCRδ antibodies were stained for CD4, ICOS, CD40L, OX40, 
and NK1.1 expression.  
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stimulation on anti-TCRδ-coated plates, Itk-/- cells up-regulated both CD40L and 
OX40, whereas wild type γδ T cells did not.  This up-regulation of CD40L and 
OX40 was detected on all subsets of Itk-/- γδ T cells (Figure 2.11B).  Finally, we 
could not detect expression of CD70 on either wild type or Itk-/- thymic γδ T cells. 
 
Discussion 
Overall, our data indicate that γδ T cell development is significantly altered 
in the absence of Itk, yielding increased numbers of γδ T cells and a shift in the 
major effector functions mediated by these cells.  Most strikingly, Itk-/- mice have 
elevated numbers of γδ T cells expressing CD4 and NK1.1.  Both CD4+ and 
NK1.1+ γδ T cells have been previously described to secrete IL-4 (65, 171, 172), 
which is thought to be a major “switch factor” cytokine required for IgG1 and IgE 
class switching (58).  Further, unlike the γδ T cells in wild type mice, the Itk-/- γδ T 
cells secrete large quantities of the TH2 cytokines, IL-4, IL-10, and IL13, in 
addition to the IFNγ typically secreted by activated wild type γδ T cells, correlating 
with high levels of PLZF, a transcription factor required for the function of αβ 
iNKT cells.  These findings strongly suggest that Itk signaling plays a key role in 
regulating γδ T cell lineage development. 
Itk-/- mice have previously been shown to have spontaneously elevated 
serum levels of IgG1 and IgE though the increase in IgG1 is not as severe as IgE 
(132).  Surprisingly, these altered γδ T cells are responsible for promoting 
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significant levels of spontaneous IgE secretion in Itk-/- mice as γδ T cell deficient 
Itk-/- mice do not have highly elevated IgE levels.  Based on the findings 
presented here, it is likely that the high levels of IL-4 and IL-13 produced by the 
activated Itk-/- γδ T cells are a major factor in the hyper IgE phenotype.  
Interestingly a study by Huang et. al. determined that Vγ1.1+ cells, which include 
V6 cells, are able enhance IgE responses upon immunization with OVA-alum 
(173) thereby supporting the possibility that V6 cells are the main γδ T cell subset 
responsible for the hyper IgE in Itk-/- mice.  However, further experiments are 
required with IL-4 and IL-13 deficient mice to determine if V6 cells are required to 
produce both of these cytokines for B cell activation and Ig class switching.  In 
addition, studies are required to determine if V6 cells directly promote the 
humoral response by examining if they are located within the germinal center 
where Ig class switching occurs.  CXCR5 has been shown to be important for TFH 
cells to migrate to germinal centers (60-62) and it would be interesting to see if 
Itk-/- V6 cells express CXCR5 similarly to TFH cells.  Overall our data indicate that 
activated Itk-/- γδ T cells express elevated amounts of B cell co-stimulatory 
molecules, such as ICOS, CD40L, and OX40, further suggesting that the γδ T 
cells may be directly providing help to the B cells, leading to B cell activation and 
Ig class switching.   
In humans, a variety of studies have implicated γδ T cells in allergic airway 
inflammation (8, 174), and specifically, in promoting B cell activation and IgE 
class switching (175, 176).  One interesting clinical report found that IL-4-
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producing γδ T cells were likely responsible for a case of hyper IgE syndrome (5).  
Studies performed in vitro with human γδ T cells showed that these cells, in 
combination with IL-4, can induce B cell activation, Ig isotype switching, and 
secretion of IgE (177).  Further, these findings correlate well with observations 
that human γδ T cells can express ICOS, CD40L, OX40, and CD70 (10).  Our 
data indicate that the Tec family tyrosine kinase, Itk, plays a key role in regulating 
this potentially highly detrimental function of γδ T cells.  As mentioned previously, 
Itk-/- mice also have spontaneously elevated levels of IgG1 in addition to IgE.  We 
have shown that the γδ T cells in Itk-/- mice are responsible for the hyper-IgE but 
we did not examine IgG1 in Itk/TCRd-/- mice.  It is possible that γδ T cells do not 
affect IgG1 isotype switching as one study with allergic airway inflammation 
showed that lack of γδ T cells resulted in decreased IgE production but not IgG1 
(8).  In contrast, another study determined that γδ T cells were required for both 
IgE and IgG1 (178).  Therefore, further studies are required to determine if γδ T 
cells in Itk/TCRd-/- mice affect IgG1. 
 Recently, γδ T cells have also been implicated in the elevated IgE 
concentrations seen in mice carrying mutations in additional T cell signaling 
proteins.  For instance, in the absence of the E3-ubiquitin ligase, Itch, γδ T cells 
secrete IL-4 and promote IgE production in unimmunized mice (174).  More 
strikingly, mice expressing a mutant allele of the adapter protein LAT, which 
lacks the three c-terminal tyrosines, succumb to a fatal lymphoproliferative 
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disorder that is mediated by γδ T cells (179).  In these LAT mutant mice, the γδ T 
cells accumulate to large numbers, and show a phenotype remarkably similar to 
those lacking Itk.  For instance, the LAT mutant γδ T cells secrete IL-4, rather 
than IFN-γ, and many of them express the CD4 co-receptor; in addition, the mice 
also have elevated levels of serum IgE.  As this mutant LAT protein does not 
support αβ T cell development, these altered γδ T cells are the only source of T 
cell help for B cell activation and IgE class switching.  As Itk and LAT interact in a 
TCR-dependent signaling complex in αβ T cells, the similarities in the γδ T cell 
phenotype in these two lines of mice strongly suggest that these proteins are 
also in the same signaling pathway downstream of the γδ TCR, and further, that 
this pathway regulates the development and effector function of γδ T cells.  As Itk 
has previously been shown to suppress the development of innate αβ lineage T 
cells and to promote the development of conventional αβ T cells (180), a similar 
function for Itk may be required in γδ T cells; thus, in the absence of Itk, 
enhanced development of innate (e.g., PLZF+, NK1.1+) γδ T cells occurs, leading 
to increased numbers of effector cytokine-producing γδ T cells in Itk-/- mice. 
Interestingly, a recent report by Jensen et al demonstrates that γδ T cells, 
like αβ T cells, are found as both naïve and effector subsets (44).  Effector-type 
γδ T cells express higher levels of CD44, NK1.1, and CD122 relative to the naïve 
subset, and in addition, show an altered cytokine secretion profile.  Furthermore, 
the presence of the effector γδ T cell population correlated with the expression of 
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the TCR ligand for these γδ T cells, indicating that ligand recognition was 
responsible for their activated phenotype.  As a large population of Itk-/- γδ T cells 
exhibit a similar effector cell phenotype, and produce effector cytokines such as 
IFN-γ and IL-4, these findings suggest that ligand recognition by Itk-/- γδ T cells 
may contribute to their activation in vivo, and their role in promoting IgE 
production in unimmunized mice. 
Furthermore, the increase in total γδ T cells in Itk-/-mice is due to the 
expansion of the V6 cells which have been shown to share similar characteristics 
to αβ iNKT cells such as CD4, NK1.1 and PLZF expression along with the ability 
to secrete both IL-4 and IFNγ.  Therefore, it is possible that Itk is affecting the 
maturation of the V6 cells.  Previous studies have demonstrated that lack of Itk 
negatively affects the maturation stages of iNKT cells by causing a defect during 
progression through maturation (156-158). 
These findings have substantial relevance to the potential effects of small 
molecule inhibitors of Itk.  Due to the importance of Itk in TH2 development and 
cytokine production by CD4+ αβ T cells, this kinase is currently being targeted for 
the development of drugs to treat asthma and other allergic diseases (2, 181).  It 
would be unfortunate if Itk inhibition also led to the aberrant activation of γδ T 
cells, and thus to enhanced production of IgE.  Elevated levels of serum IgE 
would, in turn, lead to up-regulation of the FcεRI on mast cells (182), promoting 
hyper-responsiveness of these cells to IgE-mediated receptor aggregation.  In 
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light of the findings presented here, further studies on the role of Itk in human γδ 
T cells is clearly warranted. 
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Introduction 
 
 The Tec family tyrosine kinase, Itk, regulates signal transduction in T cells 
via the T-cell receptor (TCR).  In the absence of Itk, T cells have defects in 
phospholipase C-γ1 (PLCγ1) activation, calcium mobilization, mitogen-activated 
protein kinase (MAPK kinase) phosphorylation, and AP-1 and nuclear factor of 
activated T cells (NFAT) activity after stimulation (183).  As a consequence, Itk 
plays a critical role in αβ T cell development, influencing both positive and 
negative selection.  During thymic development, conventional CD4+ and CD8+ T 
cells are the predominant populations that arise; these cells develop with a naïve 
phenotype (CD62Lhi/CD44lo) and require a lengthy process of activation, 
proliferation, and differentiation prior to exhibiting effector cell characteristics 
(108, 184-186).  In contrast, thymic development in Itk-/- mice produces 
populations of both CD4+ and CD8+ T cells that resemble memory cells and 
exhibit innate effector functions (187-190).  These data indicate that TCR 
signaling via Itk is not simply regulating the efficiency of conventional CD4+ and 
CD8+ T cell maturation, but also required for the appropriate balance of naïve 
versus innate T cell subsets.  
One unexpected phenotype observed in Itk-/- mice is a spontaneous 
elevation in levels of serum IgE (4, 132).  Based on a wealth of data indicating 
that Itk-/- CD4+ T cells are unable to generate TH2 effector responses (159), and 
the fact that Itk-/- αβ TCR+ iNKT (αβ iNKT) cells are also defective in producing IL-
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4 (157, 158) the source of type 2 cytokines responsible for promoting B cell 
isotype switching to IgE was initially a mystery.  However, recent studies showed 
that the cell type responsible for the hyper-IgE syndrome seen in Itk-/- mice was a 
specific subset of γδ TCR+ T cells.  These γδ T cells, expressing the Vγ1.1+Vδ6.3+ 
(V6) TCR and the transcription factor PLZF (80, 83, 191) are greatly increased in 
number in Itk-/- mice, and secrete high levels of TH2 cytokines (155).  Previous 
studies have also shown V6 cells have a restricted TCR repertoire with limited 
junctional diversity and that they originate from fetal or postnatal precursors 
which is characterized by a few to no N nucleotide additions along with 
preferential use of Dδ2 (66-68, 76).  The V6 cell subset, now known as γδ NKT 
cells, is found in the thymus, spleen and liver (66, 166).  Their preferential 
localization to the liver along with their expression of PLZF has linked them to αβ 
iNKT cells (81, 82).  In addition, transcriptome analysis of αβ and γδ NKT cells 
indicates a common molecular program among the two lineages (49).  
αβ TCR+ NKT cells are an innate subset of αβ T cells that have 
characteristics of both T and NK cells.  These lymphocytes reside in the thymus, 
spleen and liver and are rarely detected in the lymph nodes or intestine.  Unlike 
conventional T cells, αβ iNKT cells can rapidly produce large amounts of 
cytokines such as IFNγ, IL-4, and IL-10 (88, 192).  Murine αβ iNKT cells 
predominantly express an invariant TCR Vα and Jα receptor (Vα14-Jα18) that 
preferentially pairs with a restricted TCR β-chain (Vβ8.2 or Vβ7); further, this TCR 
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recognizes the glycolipid α-galactosyl ceramide (αGalcer) bound to the MHC 
class Ib molecule, CD1d (90).  
Like conventional T cells, αβ iNKT cells develop in the thymus from 
CD4+CD8+ double positive (DP) progenitors, and are dependent on the presence 
of CD1d (193-195).  Following their initial positive selection, αβ iNKT cell 
precursors undergo additional stages of differentiation in the thymus.  Starting 
with the earliest detectable population CD24+ (HSA), CD44loNK1.1lo (stage 0), αβ 
iNKT cells proceed to down-regulate CD24 (stage 1), and then up-regulate CD44 
(CD24loCD44hiNK1.1lo; stage 2).  Finally, the cells up-regulate the IL-2/IL-15 
receptor β-chain (CD122) and NK cell receptors, such as NK1.1 
(CD24loCD44hiNK1.1hi; stage 3).  Transition through these stages is also 
accompanied by a change in cytokine profile.  During stage 1 and 2, αβ iNKT 
cells are potent producers of IL-4, but make little IFNγ; this phenotype correlates 
with expression of high levels of PLZF.  As they transition to stage 3, αβ iNKT 
cells produce abundant amounts of IFNγ, but less IL-4, and PLZF expression 
decreases (9, 93, 99).  Other molecules important for αβ iNKT cell development 
include the SLAM family surface receptors and the adaptor protein SLAM-
associated protein (SAP)(95).
Previous studies have shown that Itk-/- mice have reduced numbers of αβ 
iNKT cells, and that the remaining subset of iNKT cells in these mice have a 
defect in progressing past stage 2 of development (156-158).  Even though γδ T 
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cells develop in the thymus, they develop from CD4-CD8- progenitors, rather than 
from DP thymocytes (22, 23).  Thus, it was unclear whether γδ NKT cells would 
share similar intrathymic subsets with αβ iNKT cells.  In addition, information on 
the development of Itk-/- γδ NKT cells was also lacking.  Here we show both αβ 
and γδ NKT cells in the thymus include two populations expressing distinct levels 
of PLZF.  Further, as with αβ iNKT cells, down-regulation of PLZF in γδ NKT cells 
correlates with changes in cytokine production, and up-regulation of maturation 
markers.  We also find that γδ NKT cells in Itk-/- mice are impaired in this 
progression, leading to increased numbers of PLZF+ IL-4-producing γδ NKT cells 
in the periphery of these mice relative to wild type mice.  Finally, we investigated 
the TCR repertoire of γδ NKT cells in the thymus versus the periphery, and find 
that γδ NKT cells are generated from both fetal and adult precursors in two waves 
with Itk-/- thymus containing more γδ NKT cells being generated from fetal 
precursors.  These data support a similar developmental progression for γδ NKT 
cells as for αβ iNKT cells, and indicate that Itk plays a parallel role in the 
functional and phenotypic maturation of both subsets of NKT cells. 
 
Results 
 
V6 cells display an immature phenotype in the spleens of Itk-/- mice  
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We have previously shown that the absolute number and proportion of γδT 
cells are increased in the thymus, spleen and liver of Itk-/- mice.  This defect can 
be attributed to a specific subset of γδT cells expressing the Vγ1.1+Vδ6.3+ (V6) 
TCR (155) (Figure 3.1A).  Numerous similarities between V6 cells and αβ iNKT 
cells have been observed, we therefore hypothesized that V6 cells develop in a 
similar manner to αβ iNKT cells and that lack of Itk affects splenic V6 cells 
similarly to αβ iNKT cells.  Splenic αβ iNKT cells were compared side by side 
with V6 cells.  Consistent with previous reports, αβ iNKT cells from Itk-/- mice are 
reduced approximately two fold in both number and percent (156-158).  To 
assess whether or not V6 cells in the spleen had similar characteristics to αβ 
iNKT cells, CD1d tetramer and γδ antibodies were used to identify αβ iNKT cells 
and V6 cells.  In addition αβ iNKT and V6 cells were further stained with 
antibodies specific for cell surface markers and transcription factors associated 
with mature αβ iNKT cells such as CD122, CD44, CD4 and PLZF (99).  
Phenotypic analysis of HSA- V6 cells and αβ iNKT cells from the spleens of wild 
type mice show that the majority of these cells express the activation markers 
CD44 and CD122 (Figure 3.1B and C) which are up-regulated on mature αβ 
iNKT cells (156, 196).  In addition, there is a population of αβ iNKT and V6 cells 
that are PLZF+ along with a proportion of both populations that remained CD4 
positive (Figure 3.1B).   
In contrast, examination of αβ iNKT and V6 cells from Itk-/- mice reveals a  
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Figure 3.1: Spleen V6 cells in Itk-/- mice have increased expression of PLZF 
and IL-4 transcription.   
Cells were prepared from spleens of wild type and Itk-/- mice or 4Get and Itk-4Get 
mice and analyzed by flow cytometry.  (A) Splenocytes were stained with anti-
TCRδ for γδ T cells.  γδ T cells were further stained with anti-Vγ1.1 and anti-Vδ6.3 
to examine the V6 population.  iNKT cells were also examined by staining with 
CD1d tetramer and anti-TCRβ.  (B) HSA- V6 γδ T cells and iNKT cells were 
further analyzed for expression of CD44, CD122, CD4 and PLZF.  Percentage of 
HSA- V6 γδ T cells and iNKT CD44+, CD122+ and CD4+ are shown.  Each data 
point represents one mouse with the black bar indicating the mean.  (C) HSA- V6 
γδ T cells and iNKT cells from 4Get and Itk-4Get mice were stained and analyzed 
for CD44 vs GFP, CD122 vs GFP and CD4 vs GFP.  Data are representative of 
at least two independent experiments.  (D) Absolute numbers of PLZF+ cells, % 
and absolute numbers of GFP+ from HSA- V6 γδ T cells and iNKT cells are 
shown.   
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drastically altered phenotype when compared to wild type controls.  While the 
majority of Itk-/- V6 cells express CD44 and CD122, like wild type cells, they retain 
expression of PLZF and CD4, suggesting that Itk-/-  V6 cells are similar to the Itk-/- 
αβ iNKT cells.  We then wondered whether this altered phenotype correlated with 
altered functionality as previous studies have demonstrated that as αβ iNKT cells 
mature IL-4 production decreases (156).  Using bicistronic IL-4/enhanced GFP 
reporter (4Get) mice (197) we were able to compare the proportion of HSA- αβ 
iNKT and V6 cells expressing IL-4 in the presence or absence of Itk.  As shown 
in Figure 3.1C, the vast majority of V6 cells from Itk-/- mice were GFP positive 
compared to V6 cells from wild type controls similar to what is seen for wild type 
and Itk-/- αβ iNKT cells.   In both αβ iNKT and V6 cells from wild type and Itk-/- 
4Get mice, cells were CD44+ and GFP+ yet upon examination of CD122, while 
many of the wild type 4Get αβ iNKT and V6 cells were CD122+ and very few 
GFP single positive, αβ iNKT and V6 cells from Itk-/- mice were still GFP single 
positive. This is consistent with the possibility that Itk-/- αβ iNKT and V6 cells are 
leaving the thymus at an immature stage.  Interestingly, the cell surface 
phenotype of V6 cells from 4Get mice matched the cell surface phenotype of 
PLZF expressing V6 cells (Figures 3.1B and C), a trend that remained true in Itk-/- 
mice as well.  Finally, Figure 3.1D shows that the total number and proportion of 
GFP positive cells is significantly increased in Itk-/- mice compared to WT 
counterparts.  This observation is also true when looking at PLZF positive cells, 
indicating a correlation between PLZF expression and IL-4 transcription.  Taken 
83
together, these data indicate that the majority of V6 cells from the spleens of Itk-/- 
mice display an immature phenotype. 
 
Itk-/- V6 cells do not mature in the periphery 
It remained to be seen, however if the V6 cells from Itk-/- mice displayed this 
immature phenotype throughout the periphery or only in the spleen.  Since it is 
well documented that αβ iNKT cells continue to mature in the periphery (98, 100) 
we next examined these populations in the liver where αβ iNKT and V6 cells 
preferentially home (68, 99) to examine whether or not αβ iNKT and V6 cells 
continued to express elevated levels of PLZF and GFP in the liver.  Indeed, the 
percentage of both αβ iNKT cells and V6 cells expressing low levels of PLZF 
from wild type mice are increased in the liver compared to the splenic 
compartment (Figure 3.2A).  Furthermore, the majority of V6 cells from Itk-/- mice 
continue to display an immature phenotype, expressing both CD4 and PLZF 
(Figure 3.2A).  Consistent with data from the spleen, V6 cells from the livers of 
Itk-/- 4Get mice remain positive for GFP compared to wild type counterparts 
(Figure 3.2B).  One of the hallmarks of innate T lymphocytes is a restricted TCR 
repertoire (11).  Therefore we wanted to examine the TCR delta usage of V6 
cells from the livers of wild type and Itk-/- mice.  Sequencing of the TCR also 
allows for closer examination of whether or not V6 cells were generated from 
fetal precursors or adult precursors based upon N nucleotide additions (76).  As 
expected V6 cells from wild type mice exhibit limited diversity in their TCR delta 
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Figure 3.2: Liver V6 cells in Itk-/- mice display an immature phenotype.   
Cells were prepared from livers of wild type and Itk-/- mice or 4Get and Itk-4Get 
mice and analyzed by flow cytometry.  (A) Wild type and Itk-/- HSA- V6 γδ T cells 
and iNKT cells were analyzed for expression of CD4 and PLZF.  Percentage of 
HSA- V6 γδ T cells and iNKT PLZF+ cells are shown.  (B) 4Get and Itk-4Get HSA- 
V6 γδ T cells and iNKT cells were analyzed for expression of CD4 and PLZF.  
Percentage of HSA- V6 γδ T cells and iNKT PLZF+ cells are shown.  Each data 
point represents one mouse with the black bar indicating the mean.  (C) Chart 
represents sequences and classification of sequences of Vδ6 and Jδ1 junctions 
from sorted V6 γδ T cells from wild type and Itk-/- livers.  
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usage, using only two unique sequences.  These sequences very few N 
nucleotide additions suggesting that rearrangement occurred prior to TdT 
expression.  In addition, all the sequences lack the Dδ1 gene segment and use of 
the canonical Dδ2-Jδ1 junction (Figure 3.2C and Figure 3.3).  This suggests that 
wild type V6 livers cells in the liver develop from fetal or postnatal precursors.  In 
contrast, V6 cells from Itk-/- mice use four unique sequences, three of which are 
not even found in the livers of wild type mice (Figure 3.2C and Figure 3.3).  
Interestingly, only one of the V6 sequences found in Itk-/- mice contains N 
nucleotide additions suggesting that this particular sequence was generated from 
an adult precursor.  The inability of V6 cells from Itk-/- mice to restrict their TCR 
usage suggest that the majority of V6 cells in periphery of Itk-/- mice are 
immature. 
 
Developmental progression of V6 cells is impaired in Itk-/- mice 
 The data thus far indicate that Itk is important in mediating the maturation 
of V6 cells and that in its absence V6 cells are inefficiently transitioning through 
the maturation stages similar to Itk-/- αβ iNKT cells.  We therefore decided to 
inspect the thymi of wild type and Itk-/- mice by examining the expression of CD4, 
CD122, CD44 and PLZF expression on αβ iNKT and V6 cells to determine if and 
where the defect occurs.  As observed previously, the percentage of iNKT cells in 
Itk-/- mice is decreased by approximately half compared to wild type mice  (Figure 
3.4A) (155, 157, 158).  On the other hand, a substantial increase in the   
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Figure 3.3: Liver sequence analysis of Vδ6-Jδ1 junctions 
Shown sequences are the junctional regions of Vδ6 (variable region), Dδ1 and 2 
(diversity region) and Jδ1 (joining region) rearrangements in 17 wild type- and 14 
Itk-/--V6 clones, respectively.  Palindromic (P) and N nucleotides are marked in 
red color.  Polymorphic sequences are compared to the germline sequence.  The 
frequency (left) implies the clone numbers for the sequence and simple note 
(right) marks brief classification of each sequence.  After sequencing, off-frame 
sequences were not considered. 
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Figure 3.4: Absence of Itk results in a partial block in γδ  NKT cell 
maturation.   
Cells were prepared from thymuses of wild type and Itk-/- mice or 4Get and Itk-
4Get mice and analyzed by flow cytometry.  (A) Thymocytes were stained with 
anti-TCRδ for γδ T cells.  γδ T cells were further stained with anti-Vγ1.1 and anti-
Vδ6.3 to examine the V6 population.  iNKT cells were also examined by staining 
with CD1d tetramer and anti-TCRβ.  (B) HSA- V6 γδ T cells and iNKT cells were 
further analyzed for expression of CD44, CD122, CD4 and PLZF.  Percentage of 
HSA- V6 γδ T cells and iNKT cells CD44+, CD122+ and CD4+ are shown.  Each 
data point represents one mouse with the black bar indicating the mean.  (C) 
HSA- V6 γδ T cells and iNKT cells from 4Get and Itk-4Get mice were stained and 
analyzed for CD44 vs GFP, CD122 vs GFP and CD4 vs GFP.  Data are 
representative of at least two independent experiments.  (D) PLZF hi and 
intermediate V6 γδ T cell and iNKT cell populations were gated as shown in B 
and absolute numbers are shown.  Percent and absolute numbers of GFP+ from 
HSA- V6 γδ T cells and iNKT cells are shown.  
90
 
0.24
0.15
0.25
13.4
11.4
0.85
13.8
54.4
WT
Itk-­/-­
TC
R
?
TCR ?
V
?1
.1
V?6.3 TCR ?
C
D
1d
T
et
Total
thymocytes iNKT cells?? T cells
A
23.8 67.3
8.530.47
19.2 65.8
4.3510.5
2.31 37.5
57.72.45
0.90 57.3
41.10.67
WT
Itk-­/-­
C
D
44
PLZF
iNKT cellsV6 ?? T cells
2.99 60.2
35.51.36
0.71 46.9
51.90.47C
D
12
2
22.8 56.8
19.11.51
15.1 29.3
40.914.6
PLZF
0.68 24.3
71.53.53
0.30 71.6
27.30.80C
D
4
10.8 55.6
19.913.6
27.6 67
3.232.04
PLZF
21.9 64.4
11.72.03
31.1 33.1
341.75
1.17 16.7
50.431.7
5.63 15.6
762.83
1.16 63.8
27.87.29
5.65 40.2
35.418.7
14.2 13.7
4626.1
34.3 54.7
4.826.2
V6 ?? T cells iNKT cells
GFP
C
D
4
C
D
12
2
GFP
V6 ?? T cells iNKT cells
C
D
44
GFP
4Get
Itk-­4Get
13.6 59.7
25.41.29
18.8 80
1.170.01
2.4 73.6
20.73.29
47.2 36.7
3.3312.8
V6 ?? T cells iNKT cells
iNKT cellsV6 ?? T cells iNKT cellsV6 ?? T cells
0
20
40
60
80
100
p=0.0015
p<0.0001%
of
C
D
12
2+
ce
lls
0
20
0
60
80
100 p<0.0001
p 0.0030
%
of
C
D
4+
ce
lls
WT
V6
Itk-­/-­
V6
WT
iNKT
Itk-­/-­
iNKT
WT
V6
Itk-­/-­
V6
WT
iNKT
Itk-­/-­
iNKT
WT
V6
Itk-­/-­
V6
WT
iNKT
Itk-­/-­
iNKT
B
C
10
105
106
p 0.0101
#
iN
KT
ce
lls
103
10
105
106 p<0.0001
p<0.0001
#
V6
T
ce
lls
WT
PLZFhi
Itk-­/-­
PLZFhi
WT
PLZFint
Itk-­/-­
PLZFint
WT
PLZFhi
Itk-­/-­
PLZFhi
WT
PLZFint
Itk-­/-­
PLZFint
D
0
20
40
60
80
100
%
of
G
FP
+
ce
lls
p<0.0001
p=0.0022
103
10
105
106
#
G
FP
+
ce
lls
p<0.0001
p=0.0022
4Get
V6
Itk-­4Get
V6
4Get
iNKT
Itk-­4Get
iNKT
4Get
V6
Itk-­4Get
V6
4Get
NKT
Itk-­4Get
iNKT
0
20
40
60
80
100
p=0.0220
%
of
C
D
44
+
ce
lls
Figure 3.4
91
proportion of γδ T cells can be attributed to an expansion in the V6 cell population 
of Itk-/- mice (Figure 3.4A).  
Several stages of αβ iNKT cell differentiation have been identified 
previously using a variety of cell surface markers, cytokines, and transcription 
factors.  For example, up-regulation of CD44 and CD122 demarks a transition 
from stage 2 to stage 3 (93, 99).  Similar to αβ iNKT cells, HSA- V6 cells up-
regulate CD44 while concurrently up-regulating CD122.  A population of Itk-/- αβ 
iNKT cells remain CD122-, in contrast the majority of wild type αβ iNKT cells 
become CD122+ as has been previously shown (Figure 3.4B) (156-158).  
Compared to wild type mice, Itk-/- mice contain an increased percentage of 
CD44+ cells.  Interestingly a proportion of the V6 cells from these mice remain 
CD122- suggesting a defect during the stage 2 to stage 3 transition of the 
maturation process (Figure 3.4B).  One of the few differences between αβ iNKT 
cells and V6 cells seems to be the expression of CD4, with αβ iNKT cells largely 
remaining CD4+ and V6 cells being CD4-.  Comparing the V6 cells in the 
periphery to those in the thymus, it appears that CD4 becomes down-regulated 
during development.  However, a significant proportion of V6 thymocytes from Itk-
/- mice remain positive for this marker (Figure 3.4B).  One of the major 
transcription factors shown to be important in the development of αβ iNKT cells is 
PLZF (81, 82).  As αβ iNKT cells progress through the maturation stages, they 
begin to down-regulate PLZF (81, 82).   Given the similarities that have been 
seen in the spleen and liver between αβ iNKT cells and V6 cells we examined 
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PLZF expression in the thymus.  As both wild type and Itk-/- αβ iNKT cells and V6 
cells mature, a progressive down-regulation of PLZF occurs such that two distinct 
populations arise: PLZFhi and PLZFint (Figure 3.4B).  These populations are not 
seen in wild type αβ iNKT and V6 cells found in the spleen and liver (Figure 3.1B 
and 3.2A) where there only seems to be a corresponding population of PLZFlo/int 
population which is in agreement with studies that show that PLZF down 
regulates as αβ iNKT cells migrate out into the periphery (81, 82).  While there is 
no difference in the ratio of PLZFhi to PLZFint cells between wild type and Itk-/- 
mice (data not shown), there is an overall increase in the total number of both the 
PLZFhi and PLZFint populations in Itk-/- mice (Figure 3.4D, far left panel).   
It has been well documented that αβ iNKT cell development also 
correlates with IL-4 cytokine mRNA which results in  decreased IL-4 protein 
levels as they mature (101, 156).  Therefore we wanted to examine the ability of 
V6 cells to produce IL-4 in the presence or absence of Itk.  Using 4Get reporter 
mice crossed to Itk-/- mice, we were able to examine the various stages of both 
αβ iNKT and V6 cell development using CD44, CD122 and CD4 surface staining 
in the thymus in conjunction with IL-4 transcription.  Consistent with previous 
studies (101, 157) and in agreement with the PLZF data, wild type αβ iNKT cells 
have very few GFP single positive cells classified as stage 2 cells (Figure 3.4C).  
While Itk-/- αβ iNKT cells have increased percent of GFP single positive cells, 
overall expression of GFP is decreased in Itk-/- compared to wild type αβ iNKT 
cells (Figure 3.4D).  Closer examination of V6 cells from wild type mice show 
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three distinct populations in each of the three cell surface markers examined, 
with GFP expression correlating with each stage of development similar to αβ 
iNKT cells.  For example, as CD44 and CD122 expression is up-regulated, IL-4 
transcription decreases representing a transition from stage 3 to sage 4 with GFP 
single positive cells representing stage 2.  In Itk-/- mice however, an altered 
proportion of V6 cells in each stage of development is present.  Consistent with 
PLZF staining, it appears that the majority of V6 cells in Itk-/- mice are inefficient 
at transitioning from the GFP+CD122- to the GFP+CD122+ stage where there are 
76% compared to 34% of V6 GFP+CD122- cells in wild type mice (Figure 3.4C).  
A defect in the progression of V6 cells at these early maturation points could 
indicate an accumulation in cells that expressed PLZF as well as IL-4 
transcription similar to what is observed for Itk-/- αβ iNKT cells.  Indeed, when the 
total number of V6 cells expressing PLZF or GFP is quantified, there is a 
significant increase in Itk-/- mice compared to wild type (Figure 3.4D).  
 
Altered Cytokine Profile in Itk-/- V6 cells 
 Although the data presented above suggests that both wild type and Itk-/- 
αβ iNKT cells constitutively express IL-4 mRNA which is thought to lead to rapid 
secretion of IL-4 it was unexpected that Itk-/- αβ iNKT cells are defective in IL-4 
secretion upon stimulation with αGalCer (157, 158).  In addition, given that the 
defect in maturation of Itk-/- V6 cells was similar to the defect seen in Itk-/- αβ 
iNKT cells, it was surprising that these cells could be responsible for the hyper-
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IgE syndrome in Itk-/- mice.  We have previously shown that splenic γδ T cells in 
Itk-/- secrete high levels of IL-4 upon activation ex vivo (155).  Together this 
suggested that there might be an altered cytokine profile associated with the V6 
cell population.  Furthermore, we wanted to know if there was a correlation 
between the amount of PLZF expressed and the cytokines produced.  To this 
end, we stimulated wild type and Itk-/- thymocytes with PMA and ionomycin, 
which bypass the TCR, and examined IFNγ and IL-4 production in αβ iNKT and 
V6 cells.  Similar to wild type and Itk-/- αβ iNKT cells, V6 cells are capable of 
producing both cytokines upon stimulation (Figure 3.5A).  However, the 
proportion of wild type and Itk-/- V6 cells producing IFNγ and IL-4 simultaneously 
is far less than αβ iNKT cells.  Surprisingly, there was very little difference in the 
frequency of total Itk-/- V6 cells making IFNγ and/or IL-4 compared to wild type V6 
cells (Figure 3.5A).  Because cytokine production in αβ iNKT cells is mediated by 
PLZF and loss of PLZF in both αβ iNKT and V6 cells results in a loss of IL-4 and 
IFNγ double secretors (81-83, 97), we decided to examine PLZF-expressing V6 
cells to determine if there was a difference in whether or not PLZFhi and PLZFint 
preferentially secreted IL-4 or IFNγ.  Following PMA and ionomycin stimulation, a 
greater proportion of Itk-/- V6 cells are making IL-4 than V6 cells from wild type 
mice (Figure 3.5B).  In contrast, there is no difference in the frequency of IFNγ 
producing cells between wild type and Itk-/- V6 cells (Figure 3.5C).  As expected, 
the majority of IL-4 production appears to come from V6 cells that are PLZFhi   
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Figure 3.5: Level of PLZF expression correlates with IL-4 and IFNγ  
production.   
Intracellular staining for IL-4, IFNγ and PLZF for wild type and Itk-/-HSA- V6 
thymocytes were analyzed by flow cytometry.  (A) Non stimulated (left) and 
stimulated (right) HSA- V6 γδ T cells and iNKT cells from the thymus were 
analyzed for IL-4 and IFNγ along PLZF expression (B and C).  Wild type and Itk-/- 
thymocytes stimulated with 10ng/ml PMA and 2 µg/ml Ionomycin for 5 hours.   
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while IFNγ is primarily produced by PLZFlo cells.  Together, these data suggest 
that as cells down-regulate PLZF expression the cytokine profile changes from 
primarily IL-4 production to IFNγ, IL-4 co-producers.  Further, V6 cells from Itk-/- 
mice are defective in this cytokine transition indicating a problem with maturation. 
 
Gene signature of Itk-/- V6 cells 
 Thus far, the data suggests that wild type αβ iNKT and V6 cells develop 
along a similar pathway and a defect exists in the developmental progression of 
V6 cells when Itk is not present.  In order to better understand some of the 
molecular pathways involved in this process, we sorted V6 cells from the thymi of 
Itk-/- mice and compared them in a microarray to T cell populations found in wild 
type mice to determine the degree of similarity between αβ iNKT and V6 cells 
from wild type and Itk-/- mice.  As expected, the expression of a variety of genes 
is altered in Itk-/- V6 cells when compared with the most mature population of V6 
cells in wild type mice (Figure 3.6A, Table 3.1 and 3.2).  Using the Database for 
Annotation, Visualization and Integrated Discovery (DAVID) analysis program, 
we were able to identify numerous KEGG pathways that appeared to be 
disregulated in Itk-/- V6 cells (Figure 3.6B).  These pathways were involved in 
cytokine signaling, some of which are required for the development of T cells, as 
well as effector function, which included receptors frequently associated with αβ 
iNKT and NK cells.  As a case in point, we examined the expression of several 
NK cell receptors that can mediate effector function in αβ iNKT cells that were   
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Figure 3.6: Gene expression analysis of V6 cells.  
(A) Scatter plot showing expression of consolidated probe sets by populations of 
thymocytes from adult wild type and Itk-/- mice.  Each dot represents one gene 
(mean of all probe sets and mean of replicates); red and blue indicate genes with 
expression increased or decreased, respectively, by more than twofold (P < 0.05 
(Student's t-test); coefficient of variation < 0.5; mean expression value (MEV) > 
120 in one subset); numbers in parentheses above plot indicates total number of 
these genes.  The numbers within the plot indicate the number of up-regulated 
(red) or down-regulated (blue) genes in the comparison.  Data are from three 
independent experiments with 4–30 mice each.  (B) The 124 genes increased in 
TotalV6. Itk-/- versus MatV6.WT cells were classified into functional pathways 
using the KEGG analysis program (DAVID).  The top five pathways enriched in 
the dataset are shown along with the number of genes, the gene names, the P-
value, and the Benjamini P-value for each pathway.  (C) Venn diagram 
comparing the list of genes that were increased or decreased in NKT 
(NKT.44+NK1.1+) cells versus MatCD4 and MatCD8 single positive thymoctyes 
that were identified previously (49) with the list of 124 genes down-regulated in 
TotalV6. Itk-/- versus MatV6.WT cells.  Roughly 40% of the genes decreased in 
TotalV6. Itk-/- versus MatV6.WT cells are normally increased in NKT.44+NK1.1+ 
cells versus mature single-positives.  (D) Heat map showing relative expression 
of the 51 genes identified in 3.6C that were decreased in TotalV6.Itk-/- versus 
MatV6.WT cells and increased in NKT.44+NK1.1+ cells versus MatCD4 and 
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MatCD8 single positive thymoctyes in populations of NKT and MatCD4 cells from 
WT mice and V6 cells from WT or Itk-/- mice.  Data were log transformed, 
centered by gene row and hierarchically clustered by gene and subset.  The 
clustering dendrogram for samples is shown.  
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Table 3.1: Genes that are down-regulated between MatV6.WT and Total 
V6.Itk-/- cells.   
List of the 124 genes that were decreased in Total V6.Itk-/- cells compared to 
MatV6.WT cells.  Genes were classified as being decreased if the mean 
expression value (MEV) was changed by 2-fold or more in pair wise comparisons 
with a coefficient of variation among replicates <0.5, t-test P-value<0.05, and 
MEV>120 in at least one population.   
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Table 3.1: Genes that are down-regulated in Total V6.Itk-/- cells. 
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Table 3.2: Genes that are up-regulated in Total V6.Itk-/- cells relative to 
MatV6.WT cells.   
List of the 71 genes that were increased in Total V6.Itk-/- cells compared to 
MatV6.WT cells.  Genes were classified as being increased if the mean 
expression value (MEV) was changed by 2-fold or more in pair wise comparisons 
with a coefficient of variation among replicates <0.5, t-test P-value<0.05, and 
MEV>120 in at least one population.   
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Table 3.2: Genes that are up-regulated in Total V6.Itk-/- cells 
relative to MatV6.WT cells. 
 
1110002B05Rik 
1810011H11Rik 
2010016I18Rik 
Adh1 
AI747699 
Akap6 
Aldh2 
Aqp9 
Art2b 
Asns 
Ass1 
Atp6v0d2 
Atp8a2 
B930036N10Rik 
BC002163 
BC005685 
Ccr2 
Ccr9 
Cd4 
Cdkn1b 
Cox6a1 
Ctla2a 
D10Ertd322e 
Fam169b 
Fam46c 
Fam84a 
Gadl1 
Gm10673 
Gm10785 
Gm12643 
Gm13194 
Gm6134 
Gm6983 
Gm7239 
Gm7693 
Gm8936 
Gm9197 
Gpnmb 
Grm4 
Hc 
Hectd2 
Hist1h1b 
Impdh2 
LOC625360 
LOC641050 
Lrig1 
Lztfl1 
Mpp6 
Nrn1 
Pde7b 
Plce1 
Pttg1 
Rnf7 
Robo1 
Rpl22l1 
Rpl35a 
Rps19 
Rps3a 
Rps6ka2 
Sgk3 
Slc15a1 
Smpdl3b 
Spc25 
St8sia1 
Tdgf1 
Tex2 
Themis 
Tmie 
Trim36 
Utp3 
Vegfa 
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shown to be down-regulated in Itk-/- V6 cells compared to wild type (Figure 3.7).  
Many of the receptors that were identified to be down-regulated in the microarray 
were confirmed by flow cytometry to be decreased or absent in V6 cells from Itk-/- 
mice.  Acquisition of NK cell receptors is one of the final stages of αβ iNKT cell 
maturation (156, 195, 198) and appears to be a similar trait in V6 cells as well. 
 Given the similarity between αβ iNKT cells and V6 cells, we next used the 
αβ iNKT gene signature list generated previously by Narayan and colleagues 
(49).  Figure 3.6C is a Venn diagram comparing wild type αβ iNKT cell signature 
genes previously described (49) that were found to be increased (292 genes) 
and decreased (248 genes) in αβ iNKT cells to genes that were found to be 
down-regulated (124 genes) in Itk-/- V6 cells versus wild type mature V6 cells.  
About 40% of genes that (51 genes) are normally up-regulated in mature αβ 
iNKT cells were found to be down-regulated in Itk-/- V6 cells (Figure 3.6C).  This 
data suggests that not only are the wild type V6 cells similar to wild type αβ iNKT 
cells but that the Itk-/- V6 cells have a more immature gene profile.  Using cluster 
analysis and comparing the 51 genes that wild type αβ iNKT and Itk-/- V6 cells 
share in Figure 3.6C, the heat map shows that wild type HSA- V6 cells are similar 
to mature wild type αβ iNKT cells while the Itk-/- V6 cells are most similar to 
immature wild type αβ iNKT cells (Figure 3.6D).   
 
Thymic environment influences V6 development 
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Figure 3.7: Decreased surface expression of NK cell markers in Itk-/- V6 
cells.   
HSA- V6 thymocytes from wild type and Itk-/- mice were stained for expression of 
CD49a, 2B4, Ly49E/F, NKG2A/C/E, CD94 and CD122.  Results are 
representative of 2 experiments with at least 3 mice per group. 
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 Considering the signals important for proper V6 cell development, we 
began to wonder what role other molecules played with respect to Itk.  The 
SAP/SLAM signaling pathway (199, 200) have been shown to be important for 
the development of iNKT cells.  In addition, the SAP/SLAM pathway has also 
been suggested to contribute to the development of V6 cells, as previous studies 
have shown lack of SAP results in a decrease in V6 cells (80, 83, 191).  We 
crossed Itk-/- mice to SAP-/- animals generating a double knockout mice and 
examined the thymocytes to determine the developmental progression of the 
resulting V6 cells.     
In the absence of Itk, the overall frequency of total V6 cells along with 
PLZF-expressing V6 cells from SAP-/- mice is diminished when compared to Itk-/- 
mice (Figure 3.8A-C).  Closer inspection of the V6 cells in Itk/SAP-/- reveals that 
this difference is likely due to a severe reduction in the percentage of PLZFhi V6 
cells.  Because the PLZFhi V6 cells are responsible for the bulk of the IL-4 
production, it is likely that the levels of serum IgE return to normal (Figure 3.8D) 
due to the decrease in the PLZFhi V6 cell population and not because of an 
overall lack of total numbers, as their numbers of PLZF expressing cells are 
similar to wild type V6 cells.  Interestingly, a large proportion of PLZF- cells 
remain in the Itk/SAP-/- mice, a population that is not prevalent in both wild type 
and Itk-/- mice. Of even greater interest is the presence of PLZF- HSA+ V6 cells in 
SAP-/- mice.  These data suggest that SAP is required for certain developmental 
stages of V6 cells.  
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Figure 3.8: Itk-/- V6 cells require SAP for hyper IgE phenotype 
Thymocytes from wild type, Itk-/-, SAP-/- and Itk/SAP-/- mice were analyzed by flow 
cytometry. (A) Thymocytes were stained for γδ T cells using anti-TCRδ and 
further stained with anti-Vγ1.1 and anti-Vδ6.3 to examine the V6 population.  (B) 
HSA- V6 cells were analyzed for PLZF hi and intermediate expression for each 
genotype. (C) Absolute numbers of HSA- V6 cells expressing PLZF hi and 
intermediate were compiled.  (D) Serum obtained for each genotype were 
analyzed for IgE by ELISA. 
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Vδ sequence of adult wild type V6 cell thymocytes 
 As Itk-/- V6 cells mature we wanted to examine if there was a restriction of 
the repertoire as they go through the different maturation stages given that the 
liver V6 cells surface phenotype and sequences from Itk-/- V6 cells suggested 
that they are leaving the thymus in an immature state.  To determine if there was 
a restriction of the V6 TCR repertoire cells from wild type 4Get and Itk-/- 4Get 
mice were sorted and the Vδ6-(D)-Jδ1 junction was sequenced.  Sequence 
analysis of maturation stages 2 (CD122-GFP+), 3 (CD122+GFP+) and 4 
(CD122+GFP-) of V6 cells based upon CD122 and GFP expression from 4Get 
and Itk-/- 4Get thymocytes (Figure 3.9A and B respectively) indicated that as V6 
cells mature there does not seem to be a restriction of the repertoire as the cells 
progress through the maturation stages.  Instead a large proportion of the 
sequences (Figure 3.10) from both 4Get and Itk-/- 4Get thymocytes contain 
varying sequences of Vγ6.3 which is in contrast to the sequences found in wild 
type and Itk-/- liver (Figure 3.2C).  Given that the sequences analyzed from wild 
type V6 liver cells do not contain N nucleotide additions this suggests that wild 
type liver V6 cells do not originate from adult thymus and that there are Itk-/- V6 
cells that are derived from adult precursors migrating to the liver.  Although there 
were many different sequences of V6 cells found in the both wild type and Itk-/- 
mice there are also a mixture of sequences containing both N nucleotides and 
contain the Dδ1 gene segment indicating these V6 cells were generated from 
adult precursors.  On the other hand, there are also sequences containing only   
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Figure 3.9: V6 cells in the thymus develop from fetal and adult precursors 
Chart represents frequency and classification of sequences of Vδ6 and Jδ1 
junctions from CD122-GFP+ (Stage 2), CD122+GFP+ (Stage 3), CD122+GFP- 
(Stage 4) V6 thymocytes sorted from 4Get (A) and Itk-4Get (B) mice. 
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Figure 3.10: Thymus sequence analysis of Vδ6-Jδ1 junctions 
Sequences from the junctional regions of Vδ6 (variable region), Dδ1 and 2 
(diversity region) and Jδ1 (joining region) rearrangements in 28 (Stage 2), 25 
(Stage 3), 22 (Stage 4) 4Get V6 clones- and 25 (Stage 2), 33 (Stage 3), 18 
(Stage 4) Itk-4Get V6 clones, respectively are shown.  P/N addition regions are 
shown in red and the sequence-polymorphisms are aligned to the germline 
sequence.  The frequency (left) implies the clone numbers for the sequence and 
simple note (right) marks brief classification of each sequence. After sequencing, 
only in-frame sequences are determined. 
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ACC
GAC
AAA
A
L
W
E
L
R
G
G
I
R
A
T
D
K
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V
6.3
P/N
D
1
P/N
D
2
P/N
J
1
GCT
CTC
TGG
GAG
CTG
G
ATGGCATAT
ATCGGAGGGATACGAG
CT
ACC
GAC
AAA
A
L
W
E
L
V
I
G
G
I
R
A
T
D
K
Itk
-­/-­-­4Get
thymocyte
stage
2
(﴾CD122
-­GFP
+)﴿
(Frequency)
Fetal
precursor
(4)
GCT
CTC
TGG
GAG
C
AT
ATCGGAGGGATACGAG
CT
ACC
GAC
AAA
WT
liver
1
A
L
W
E
H
I
G
G
I
R
A
T
D
K
(1)
GCT
CTC
TGG
GAG
C
AT
ATCGGAGGGATACGAG
CT
ACC
WT
liver
1’
A
L
W
E
H
I
G
G
I
R
A
T
(1)
GCT
CTC
TGG
GAG
C
GT
ATCGGAGGGATACGAG
CT
ACC
GAC
AAA
WT
liver
1’
A
L
W
E
R
I
G
G
I
R
A
T
D
K
(1)
GCT
CTC
TGG
GAG
CTG
G
TCGGAGGGATACGAG
CT
ACC
GAC
AAA
ITKko
liver
1
A
L
W
E
L
V
G
G
I
R
A
T
D
K
(1)
GCT
CTC
TGG
GAG
CTG
ATCGGAGGGATACGAG
CT
ACC
GAC
AAA
WT
liver
2
A
L
W
E
L
I
G
G
I
R
A
T
D
K
(2)
GCT
CTC
TGG
GAG
CTG
G
C
CGGAGGGATACGAG
CT
ITKko
liver
2’
A
L
W
E
L
A
G
G
I
R
A
Adult
precursor
(1)
GCT
CTC
TGG
GAG
CT
TGAT
ATCGGAGGGATACGAG
CT
seq
5’
A
L
W
E
L
D
I
G
G
I
R
A
(2)
GCT
CTC
TGG
GAG
CTG
G
GGGATACG
G
CT
ACC
GAC
AAA
ITKko
stage2-­1
A
L
W
E
L
G
D
T
A
T
D
K
(1)
GCT
CTC
TGG
GAG
CTG
G
T
GGG
TC
CT
ACC
GAC
AAA
A
L
W
E
L
V
G
P
T
D
K
(1)
GCT
CTC
TGG
GAG
CT
TCATCG
AGGGATACGAG
CT
ACC
GAC
AAA
A
L
W
E
L
H
R
G
I
R
A
T
D
K
(1)
GCT
CTC
TGG
GAG
CTG
G
TCCTCTA
CGGAG
CT
ACC
GAC
AAA
A
L
W
E
L
V
L
Y
G
A
T
D
K
(1)
GCT
CTC
TGG
GAG
CTG
G
CATAT
ATCGGAGGGATAC
CC
GAC
AAA
A
L
W
E
L
A
Y
I
G
G
I
P
D
K
(1)
GCT
CTC
TGG
GAG
CTG
G
ATGGC
CCTT
GGATCGGGGC
A
ACC
GAC
AAA
A
L
W
E
L
D
G
P
W
I
G
A
T
D
K
(1)
GCT
CTC
TGG
GAG
CTC
G
AGCCGG
TGGCATAT
ATGTGG
CGGAGGGATACGAG
A
ACC
GAC
AAA
A
L
W
E
L
E
P
V
A
Y
M
W
R
R
D
T
R
T
D
K
(2)
GCT
CTC
TGG
GAG
TTCAAT
ATCGGAGGGATACGAG
CT
ACC
GAC
AAA
ITKko
stage2-­2
A
L
W
E
F
N
I
G
G
I
R
A
T
D
K
(1)
GCT
CTC
TGG
GAG
GAAT
ATCGGAGGGGT
G
CT
ACC
GAC
AAA
A
L
W
E
E
Y
R
R
G
A
T
D
K
(1)
GCT
CTC
TGG
GAG
C
CCTAT
ATCGGAGGGATA
GTCTTCT
CT
ACC
GAC
AAA
seq
4
A
L
W
E
P
Y
I
G
G
I
V
F
S
T
D
K
(1)
GCT
CTC
TGG
GAG
CTG
TCAT
ATGGC
ATAGGGGGGATACGAG
CT
ACC
GAC
AAA
A
L
W
E
L
S
Y
G
I
G
G
I
R
A
T
D
K
(1)
GCT
CTC
TGG
GAG
CT
ATGGCAT
ATCGGAGGGATACGAG
AAC
CC
GAC
AAA
A
L
W
E
L
W
H
I
G
G
I
R
E
P
D
K
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V
6.3
P/N
D
1
P/N
D
2
P/N
J
1
GCT
CTC
TGG
GAG
CTG
G
ATGGCATAT
ATCGGAGGGATACGAG
CT
ACC
GAC
AAA
A
L
W
E
L
V
I
G
G
I
R
A
T
D
K
Itk
-­/-­-­4Get
thymocyte
stage
3
(﴾CD122
+GFP
+)﴿
(Frequency)
Fetal
precursor
(9)
GCT
CTC
TGG
GAG
C
AT
ATCGGAGGGATACGAG
CT
ACC
GAC
AAA
WT
liver
1
A
L
W
E
H
I
G
G
I
R
A
T
D
K
(6)
GCT
CTC
TGG
GAG
CTG
G
TCGGAGGGATACGAG
CT
ACC
GAC
AAA
ITKko
liver
1
A
L
W
E
L
V
G
G
I
R
A
T
D
K
(1)
GCT
CTC
TGG
GAG
CT
T
ATCGGAGGGATACGAG
CT
ACC
GAC
AAA
WT
liver
2
A
L
W
E
L
I
G
G
I
R
A
T
D
K
Adult
precursor
(1)
GCT
CTC
TGG
GAG
CTG
ATCGGAGGGATA
TATG
CT
ACC
GAC
AAA
WT
liver
2’
A
L
W
E
L
I
G
G
I
Y
A
T
D
K
(1)
GCT
CTC
TGG
GAG
CTG
G
C
CGGAGGGATAC
CCG
CT
ACC
GAC
AAA
ITKko
liver
2
A
L
W
E
L
A
G
G
I
P
A
T
D
K
(2)
GCT
CTC
TGG
GAG
CT
CGC
CGGAGGGATACG
GG
CT
ACC
GAC
AAA
ITKko
liver
2’
A
L
W
E
L
A
G
G
I
R
A
T
D
K
(1)
GCT
CTC
TGG
GAG
C
CGGAT
ATCGGAGGGATACGAG
CT
seq
5’
A
L
W
E
P
D
I
G
G
I
R
A
(2)
GCT
CTC
TGG
GAG
CTG
G
AT
ATCGGAGGG
T
CT
ACC
GAC
AAA
ITKko
stage3-­1
A
L
W
E
L
D
I
G
G
S
T
D
K
(1)
GCT
CTC
TGG
GAG
CTG
G
AAA
GAGGGATACGAG
CT
ACC
GAC
AAA
A
L
W
E
L
E
R
G
I
R
A
T
D
K
(1)
GCT
CTC
TGG
GAG
CTG
G
AGGGGG
AT
ATCGGAGGGATACCTG
CT
ACC
GAC
AAA
seq
1
A
L
W
E
L
E
G
D
I
G
G
I
P
A
T
D
K
(2)
GCT
CTC
TGG
GAG
C
TC
CAT
ATCGGAGGGATACGAG
CT
GCC
GAC
AAA
seq
2’
A
L
W
E
L
H
I
G
G
I
R
A
A
D
K
(2)
GCT
CTC
TGG
GAG
C
TG
TAT
ATCGGAGGGATACGAG
CT
ACC
GAC
AAA
seq
7
A
L
W
E
L
Y
I
G
G
I
R
A
T
D
K
(1)
GCT
CTC
TGG
GA
CCAG
ATAT
GGCCCCCACC
CGGAGGGATACGAG
CT
ACC
GAC
AAA
A
L
W
D
Q
I
W
P
P
P
G
G
I
R
A
T
D
K
(2)
GCT
CTC
TGG
GAG
CTG
G
TCCCAGCC
GAG
CTCG
CC
GAC
AAA
ITKko
stage3-­2
A
L
W
E
L
V
P
A
E
L
A
D
K
(1)
GCT
CTC
TGG
GAG
CT
CGGAGGGATACCCC
CT
G
CT
ACC
GCC
AGA
A
L
W
E
L
G
G
I
P
P
A
T
A
R
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V
6.3
P/N
D
1
P/N
D
2
P/N
J
1
GCT
CTC
TGG
GAG
CTG
G
ATGGCATAT
ATCGGAGGGATACGAG
CT
ACC
GAC
AAA
A
L
W
E
L
V
I
G
G
I
R
A
T
D
K
Itk
-­/-­-­4Get
thymocyte
stage
4
(﴾CD122
+GFP
-­)﴿
(Frequency)
Fetal
precursor
(8)
GCT
CTC
TGG
GAG
C
AT
ATCGGAGGGATACGAG
CT
ACC
GAC
AAA
WT
liver
1
A
L
W
E
H
I
G
G
I
R
A
T
D
K
(3)
GCT
CTC
TGG
GAG
CTG
G
C
CGGAGGGATACGAG
CT
ACC
GAC
AAA
ITKko
liver
2
A
L
W
E
L
A
G
G
I
R
A
T
D
K
Adult
precursor
(1)
GCT
CTC
TGG
GAG
T
GGAGGGATACGAG
CC
CC
GAC
AAA
A
L
W
E
W
R
D
T
S
P
D
K
(1)
GCT
C
C
AT
ATCGGAGGGATACG
GAA
A
L
W
E
L
P
Y
R
(2)
GCT
CTC
TGG
GAG
CT
CCCAT
ATCGGAGGGATACG
GAA
ITKko
stage4
A
L
W
E
L
P
Y
R
R
D
T
E
(1)
GCT
CTC
TGG
GAG
CT
C
T
ATAT
GGCCCCT
ATCGGAGGGATACGAG
CT
ACC
GAC
AAA
A
L
W
E
L
Y
M
A
P
I
G
G
I
R
A
T
D
K
(1)
GCT
CTC
TGG
GAG
C
CAG
ATAT
C
GGG
G
CT
ACC
GAC
AAA
seq
3
A
L
W
E
P
D
I
G
A
T
D
K
(1)
GCT
CTC
TGG
GAG
C
CTTCT
ATCGGAGGGATACGA
AT
C
GAC
AAA
A
L
W
E
P
S
I
G
G
I
R
I
D
K
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one to two nucleotide additions and use of the Dδ2-Jδ1 junction indicating they 
were generated from fetal precursors (Figure 3.10).  Sequences that were 
determined to be from fetal precursors were based upon sequences that have 
been previously published (76)  Examination of the frequency of sequences from 
adult precursors from wild type 4Get and Itk-/- 4Get V6 thymocytes from each 
maturation stage indicate that there are fewer sequences from Itk-/- V6 
thymocytes being generated from adult precursors (Wild type 4Get: 43%, 84%, 
77%, Itk-/- 4Get: 60%, 52%, 39% of V6 cells generated from adult precursors from 
Stage 2, 3, and 4 respectively)(Figure 3.10).  This data also demonstrates that 
there are more V6 cells being generated from fetal precursors in the thymus of 
Itk-/- 4Get mice. 
Wild type liver sequence 1 was represented in both wild type and Itk-/- 
livers (Figure 3.2C).   Upon closer examination of the sequences found in wild 
type 4Get and Itk-/- 4Get thymocytes, wild type liver sequence 1 was found in all 
three V6 stages from wild type 4Get and Itk-/- 4Get mice.  Interestingly, there was 
a higher proportion of wild type liver sequence 1 found in all three V6 stages of 
Itk-/- 4Get thymocytes suggesting that these V6 cells are accumulating in the 
thymus while at the same time other V6 cells with different sequences are 
migrating into the periphery.  In addition, the three thymic V6 cell subsets 
analyzed in wild type mice suggest that they are related given many of the 
shared sequences represented in each of the different maturation subsets are 
found in both wild type 4Get or Itk-/- 4Get mice.  Alternatively, it is also possible 
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that the similar sequences found in each subset maybe accumulating in each 
maturation stage.   
 
Discussion 
 
The role of Itk in conventional αβ T cell development, differentiation and 
function has been well documented (146, 159, 183, 201).  Although it has been 
previously shown that Itk is dispensable for the development of CD8+ innate T 
cells (187-189) previous reports have demonstrated that Itk is required for the 
development and maturation of αβ iNKT cells (156-158).  One report showed that 
along with a decrease in number of iNKT cells in the thymus and periphery of Itk-
/- mice, Itk-/- αβ iNKT cells also had defects in the final maturation stage (156-
158).  
Although Itk seems to play different roles between CD8+ T cells and αβ 
iNKT cells there are general similarities shared between nonconventional T cell 
lineages, some lineages appear to be more related to each other than others.  V6 
cells were previously reported to share phenotypic and functional characteristics 
with αβ iNKT cells in terms of their surface phenotype, tissue distribution, 
cytokine response and transcription factor expression (66-69, 83, 155, 191).  
Even though there are many similarities between V6 and αβ iNKT cells, studies 
have not been performed to determine if V6 cells develop in a similar manner to 
αβ iNKT cell.  In the absence of Itk we have previously shown that there is an 
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expansion of CD4+ γδ T cells along with an enriched V6 population.  The V6 cells 
have the ability to rapidly produce large quantities of IL-4 and IL-13 in addition to 
the ability to secrete IFNγ.  These cells also express the transcription factor 
PLZF.  In addition to the expansion of V6 cells in Itk-/- mice, TCRα-/- (202), KLF2-/- 
(203), and Id3-/- mice (86, 87) also have an expansion in V6 cells.  Given that αβ 
iNKT cells and V6 cells diverge early during thymic development, it is interesting 
that they can acquire the expression of the same transcription factor, PLZF, 
suggesting that these two populations of cells may undergo nearly identical 
differentiation programs (80-83, 191).  In this study, we compare the maturation 
of V6 cells to αβ iNKT cells and show that Itk-/-V6 cells have a partial block in 
maturation.  
αβ iNKT cell developmental stages are associated with defined changes in 
surface marker expression and functional changes.  In addition to confirming the 
role of Itk in αβ iNKT maturation in this study, our data suggests that adult wild 
type αβ iNKT and V6 cells mature in a similar manner.  We find that wild type V6 
cells, similar to wild type αβ iNKT cells, express two distinct populations of cells 
positive for PLZF, along with CD4 and contain IL-4 mRNA transcripts.  In 
addition, as wild type V6 cells mature they begin to down-regulate PLZF, CD4 
and IL-4 transcription.  At the same time, wild type V6 cells, similar to wild type 
αβ iNKT cells begin to up-regulate CD44, CD122 and NK cell surface markers 
(Figure 3.4 and 3.7).  The NK cell surface markers were mainly found on PLZF-/lo 
V6 cells suggesting that as V6 cells mature they up-regulate NK cell markers 
124
similar to αβ iNKT cells (156, 195, 198).  αβ  iNKT cell development has also 
been shown to be affected by the SAP/SLAM signaling (199, 200).  We find that 
while V6 development is influenced by lack of SAP, a population of V6 cells still 
persists unlike αβ iNKT cells though many of the V6 cells still present are HSA+ 
compared to wild type V6 cells (Figure 3.8A and B) indicating that SAP may have 
a role during stage 1 and 2 of maturation when HSA is down-regulated.  In 
addition to αβ iNKT cells and V6 cells requiring many of the same molecules for 
development, global gene-expression analysis of wild type αβ iNKT cells 
compared to wild type V6 cells suggests that these two cell populations are 
similar.  This data taken together indicates that despite αβ iNKT cells and V6 
cells diverging during development, they share a common maturation pathway.  
While our data suggests that αβ iNKT cells and V6 cells mature through similar 
pathways, further experiments need to be performed on V6 cells in which each 
stage would need to be sorted and transferred back into mice to determine if they 
can continue to mature.    
Upon closer examination of the maturation pathway of Itk-/- V6 cells we 
find that, similar to Itk-/- αβ iNKT cells, Itk-/- V6 thymocytes are impaired in 
maturation since they do not down-regulate PLZF and IL-4 transcription and they 
have a defect in up-regulating CD122 (Figure 3.4).  In addition, Itk-/- V6 cells are 
defective in up-regulating NK cell markers (Figure 3.7) further suggesting that Itk-
/- V6 thymocytes have a defect in maturation similar to Itk-/- αβ iNKT cells.  Global 
gene-expression analysis of Itk-/- V6 thymocytes compared to mature and 
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immature αβ iNKT cells further supported these results as Itk-/- V6 thymocytes 
were hierarchically clustered with immature αβ iNKT cells (Figure 3.6D).  Further 
evidence supporting that Itk-/- V6 cells are more immature was demonstrated by 
examining PLZF expression in the spleen (Figure 3.1B).  In wild type αβ iNKT 
cells and V6 cells there is only a PLZFlo population of cells.  However, Itk-/- αβ 
iNKT cells and V6 cells contain a PLZFhi along with a PLZFlo population of cells in 
the spleen indicating that a proportion of the Itk-/- V6 cells are migrating out into 
the periphery with αβ iNKT stage 2/3 characteristics.  Due to limitations of 
staining of PLZF and IL-4 transcription levels together, intracellular staining on 
PMA/Ionomycin stimulated thymocytes was performed instead.  Similar to what 
another group has shown, while both αβ iNKT and V6 PLZFhi and PLZFlo cells 
can produce IL-4, αβ iNKT and V6 PLZFlo cells predominantly produce IFNγ 
(Figure 3.5B and C)(80, 204).  Given that there is an accumulation of immature 
V6 PLZFhi cells in the spleen that preferentially secrete IL-4 in the Itk-/- mice, it is 
likely that these cells are responsible for the hyper IgE syndrome in Itk-/- mice. 
Interestingly, Itk seems to affect TCR signaling differently between V6 cell 
and αβ iNKT cells.  We and others show that while Itk-/- iNKT cells constitutively 
contain mRNA for IL-4 and are poised for cytokine synthesis (Figure 3.1C, 3.2B 
and 3.4C, (157)), stimulation through the TCR failed to produce effector 
cytokines.  Similar to Itk-/- αβ iNKT cells, Itk-/- V6 cells also constitutively contain 
mRNA for IL-4, but in contrast, Itk-/- V6 cells produce effector cytokine after 
stimulation through the TCR.  These results suggest that while Itk-dependent 
126
signals are not required for activation of cytokine loci in either αβ iNKT cells or V6 
cells, Itk is required for regulating effector function and development of V6 cells.
It still remains unclear as to why there expansion of V6 cells in Itk-/- mice.  
Examination of cell cycle status determined by Ki-67 staining of Itk-/- V6 cells 
showed a decrease in Ki-67+ fraction compared to wild type V6 cells 
(unpublished observation).  Proliferation rates determined by BrdU labeling also 
showed that Itk-/- V6 cells proliferated less then wild type V6 cells (unpublished 
observation).  It is possible that by examining the V6 cell population as a whole 
we may not see any differences in Ki-67 staining.  Similar to αβ iNKT cells wihich 
are very heterogeneous in their function given the recent discovery of an IL-17- 
secreting αβ iNKT cell population (205), V6 cells can also be divided into two 
distinct subsets based upon their expression of PLZF (204).  Therefore it is 
possible that a subset of V6 cells may be expanding.  A study has also 
suggested that αβ iNKT cells compete for a thymic niche with V6 γδ NKT cells, 
specifically the V6 cells that express NK1.1 (204).  However, β2m-/- mice, which 
lack iNKT cells, do not have an increase in proportions of γδ T cells (44) or γδ 
NKT cells (unpublished observation) which makes it unlikely that this is the case.  
This data together suggests that Itk-/- V6 cells are not proliferating to fill a niche 
and that they are not dying.  This may be due to lack of negative selection or 
down-regulation of anti-apoptotic molecules such as Fasl and Gzmb (Table 3.1). 
A hallmark characteristic of innate T lymphocytes is the use of a restricted 
TCR repertoire as these cells mature (11).  Analysis of wild type V6 liver Vδ6-Jδ1 
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sequences for N nucleotide additions demonstrated diversity in their TCR delta 
chain usage indicating that these cells do not restrict their repertoire as they go 
through the maturation stages (Figure 3.3 and 3.10). Instead studies have 
proposed that a large proportion of V6 cells in adult mice are the progeny of 
precursors that originate from fetal thymuses while a smaller proportion of V6 
cells that develop in the adult thymus are from adult precursors (76).  During 
early T cell ontogeny, T cell receptors contain limited diversity at the junction of 
the V, diversity (D) and joining (J) segments (206, 207) due to the absence of 
terminal deoxylnucleotidyl transferase (TdT).  TdT is a polymerase that adds 
non-templated nucleotides that is absent in embryonic cells but begins to be 
expressed in developing thymocytes three to five days after birth resulting in TCR 
chains lacking N region additions during fetal and early post-natal life (71-75).  
V6 cells first arise in the thymus after birth and their numbers are thought to 
greatly expand during the first weeks of life (66).  Interestingly, the gene 
arrangements associated with the V6 population are typically found in the fetal 
rather than the adult thymus.  Characteristics of gene arrangements found in the 
fetal thymus include minimal to no N nucleotides at junctions, in addition to the 
presence of a single D element in the rearranged δ-chain gene (66, 67, 70).  
These characteristics are also associated with the V3 population of γδ T cells that 
migrate to the skin (208) which develop around embryonic day 14 (30, 34).  
Examination of the TCRδ chain of V6 cells in the liver of Itk-/- mice compared to 
wild type V6 liver cells (Figure 3.2C) revealed an increase in the number of TCRδ 
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sequence usage.  Interestingly, in wild type V6 liver cells, the two sequences 
present lacked N sequence additions whereas one of the most represented 
sequences in Itk-/- V6 liver cells contained N nucleotide additions (Figure 3.3).  
Lack of N nucleotide additions and predominant use of the Dδ2 gene segment in 
wild type V6 liver cells indicate that these cells develop from fetal precursors, 
where as in Itk-/- V6 cells, some of the V6 cells but not all the cells could have 
developed later in life.  This data Indicates that perhaps lack of Itk may be 
affecting the selection of the V6 cells where cells that would normally be selected 
against are now being selected for in the thymus.  
GFP- V6 cells found in the thymus (Figure 3.4C) of wild type and Itk-/- mice 
consist of both invariant V6 receptors and receptors containing N nucleotide 
additions and use of Dδ1 segment.  This indicates that the adult thymus contains 
V6 cells that developed from both fetal and adult precursors.  Like αβ iNKT cells, 
a small portion of V6 cells reside in the thymus after maturation (76, 209).  Wild 
type V6 cells that developed from fetal precursors found in the thymus may have 
accumulated there after development similar to thymic resident αβ iNKT cells.  
There seemed to be an overall increase in Itk-/- V6 cells in the thymus that 
developed from fetal precursors indicating Itk may be affecting the migration of 
V6 cells.  Consistent with this idea, Itk has been shown to be involved in the 
migration of T cells and that lack of Itk results in defects in chemokine induced 
migration (210).  Alternatively, as mentioned above these cells may normally be 
selected against, but in the absence of Itk they may be passing negative 
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selection due to defective TCR signaling.  Supporting this theory includes studies 
that have shown that γδ T cells that recognize the ligands T10 and T22 have 
been found in the epithelial layer of the small intestine (IEL) in mice lacking the 
nonclassical MHC class I molecules T10 and T22 (211).  Along with the 
development of T10/T22 specific γδ cells in the absence of ligand, there is also 
an increase of T10/T22 specific cells in the IEL compartment indicating that there 
is some type of selection process occurring (211).  While the ligand is not known 
for V6 cells, it is possible that something similar is occurring with Itk-/- V6 cells 
given that they have defective TCR signaling. 
The sequencing data also clarifies some of the inconsistent data regarding 
the development of V6 cells in Id3-/- and Itk-/- mice.  Id3 (inhibitor of DNA binding 
3) belongs to the ERK-Egr-Id3 signaling pathway and is induced upon TCR 
signaling (85) therefore, Id3 is downstream of Itk.  Previous reports demonstrated 
that similar to Itk-/- mice, Id3-/- mice had a similar increase in V6 cells (80, 86).  
We previously showed reconstitution of wild type mice with Itk-/- bone marrow 
resulted in reconstitution of the V6 population (155); whereas reconstitution of 
wild type mice with Id3-/- bone marrow failed to reconstitute the V6 population 
(191).  Based upon our findings, we propose Id3 affects the development of the 
V6 cell population that develops during the late fetal or neonatal wave resulting in 
the lack of V6 cell reconstitution in bone marrow chimeras; while lack of Itk 
affects the development of V6 cells generated in the neonatal and adult thymus. 
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Further experiments should examine V6 cells from neonatal Itk-/- mice.  All 
the experiments in this chapter have examined V6 cells in adult mice yet V6 cells 
are thought to expand during the first few weeks after birth (76).  Therefore it 
would be interesting to examine the V6 cell population in Itk-/-neonatal mice.  In 
addition, it would also be of interest to sort for the different stages of V6 cells to 
examine the sequence variation to determine if there is a difference between wild 
type and Itk-/-neonatal mice. 
In this study, we elucidated the role of Itk in the maturation stages of V6 
cells and that the lack of Itk results in V6 cells that migrate out into the periphery 
in an immature state, which can lead to hyper IgE.   Additionally, in the absence 
of both αβ and γδ T cells with regulatory properties, V6 cells can cause 
uncontrolled inflammation due to recruitment of granulocytes and lymphocytes 
(83).  While we do not see this in our model due to the presence of regulatory 
cells, our data indicates that Itk plays an important role in regulating the 
maturation and function of V6 cells. 
 
 
 
 
 
 
131
 
 
 
Chapter IV: Discussion 
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Some of the material in the discussion was derived from a manuscript that has 
been submitted by Malhotra et al. [figure 4.1] or has been published by Prince et 
al., 2009 Immunological Reviews review [figures 4.2-4.4] (9). All of the material 
derived from papers was from sections originally written by me. 
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Synopsis of the material 
 
 The cell mediated immune response evolved over 450 million years ago 
when jawed vertebrates diverged from jawless fish, to play a crucial role to 
defend against numerous pathogens (212).  While we have a greater 
understanding of B and αβ T cells, much less is known about γδ T cells and the 
role Itk plays in the development and function of these cells.  Previous studies 
have shown Itk deficiency in mice resulted in the failure to mount an effective TH2 
response (213).  Given the profound effects of Itk on TH2 responses, it has 
become an attractive target for the development of drugs to treat asthma and 
other diseases of hypersensitivity.  However, recent data has demonstrated 
aberrant Itk expression in humans result in fatal consequences.  Therefore, a 
better understanding of the role of Itk in cells aside from TH2 cells is required.  
The data presented in this thesis clearly demonstrates a role for Itk signaling in 
regulating γδ T cell lineage development, maturation and effector function. 
 It has been long observed that naïve Itk-/- mice have spontaneously 
elevated serum IgE levels despite the observed defects in TH2 cytokine secretion 
from conventional CD4+ and iNKT cells.  In Chapter II, we show in the absence of 
Itk, a specific subset of γδ T cells is responsible for the spontaneously elevated 
serum IgE levels in Itk-/- mice as mice deficient in both Itk and TCRδ have normal 
levels of serum IgE.  Upon stimulation through the TCR, Itk-/- γδ T cells secrete 
low levels of IFNγ but high levels of TH2 cytokines.  In addition, we found an 
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increase in γδ T cell numbers in Itk-/- mice, most notably the V6 population that 
also has an increase in CD4 expression.  The V6 population has previously been 
described to be the dominant population of γδ NKT cells.  Aside from Itk-/- γδ T 
cells secreting large amounts of IL-4, these cells are also PLZF+, which indicates 
that there is a common molecular program between αβ iNKT and V6 cells. 
 Chapter III described an important role for Itk in the terminal maturation of 
the V6 γδ NKT cells.  The data from Chapter II, along with previous studies (66, 
69, 76), and high transcriptome analysis of αβ iNKT and V6 cells (49) indicate 
that there is a common molecular program between αβ iNKT and V6 cells.  
Therefore, we further examined whether V6 cells demonstrate similar maturation 
properties to αβ iNKT cells.  We investigated V6 cell development in the 
presence and absence of Itk and compared these data to parallel analyses of αβ 
iNKT cell maturation subsets in the thymus.  In the presence of Itk, the subsets of 
V6 and αβ iNKT cells show strong similarities in maturation based upon CD122, 
CD4, CD44, PLZF and IL-4 expression.  These similarities suggest that these 
subsets undergo similar differentiation programs.  The absence of Itk in V6 cells 
resulted in impaired maturation of these cells in the thymus, as illustrated by the 
inability of V6 cells to up-regulate NK cell markers and CD122.  This impairment 
in maturation is similar to defects previously seen (156-158) in the terminal 
differentiation of Itk deficient αβ iNKT cells.  The hyper-IgE syndrome seen in Itk-/- 
mice can be attributed to the requirement for Itk in the terminal maturation of V6 
cells, a process normally accompanied by down-regulation of PLZF and IL-4 
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production.  Therefore, data in this chapter demonstrates that wild type V6 cells 
progress to a mature stage of development in a parallel manner to αβ iNKT cells 
and that Itk is required for proper development and function of both αβ iNKT and 
V6 cells. 
 Overall, my thesis extends the general knowledge of the development and 
function of V6 cells and the role Itk plays in this subset.  Specifically, we 
demonstrate that Itk is required for terminal maturation and function of V6 cells.  
Our data also indicates each γδ T cell subset should be examined as an 
individual population since the absence of Itk affected some γδ T cell subsets (i.e. 
V6 cells), but not all.  This can be due to not all γδ T cell populations being 
equally affected given that each subset has differing signal requirements.  The 
following sections will attempt to reconcile the role of Itk in V6 cells and some of 
the questions that were raised based upon findings presented in the previous 
chapters. 
 
Alternative signaling pathways in V6 cells 
 
 Three Tec family kinases are expressed in conventional αβ TCR T cells, 
Itk, Rlk and Tec with Itk being the predominant kinase in these cells.  Upon 
stimulation of the αβ TCR, a cascade of signaling events is initiated where ZAP-
70 and LAT are recruited and activate Itk to further propagate the signaling 
cascade.  This results in the ability of αβ T cells to synthesize effector cytokines.  
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Therefore, it is not surprising that the lack Itk in αβ T cells results in defects in 
Ca2+ mobilization and Erk activation that affect the synthesis of effector 
cytokines.  In Chapter II, we find the absence of Itk in V6 cells resulted in an 
expansion of these cells.  In addition, V6 cells have the ability to produce large 
amounts of IL-4 following stimulation through their TCR despite the inability of γδ 
T cells lacking Itk to flux calcium (Figure 4.1).  This finding raises an interesting 
issue regarding the development and signaling properties of γδ T cells.  Similar to 
αβ T cells lacking Itk, γδ T cells appear to have dampened TCR signals in the 
absence of Itk.  However, in contrast to αβ T cells lacking Itk, γδ T cells still have 
the ability to produce cytokines.  Therefore it is possible that the signaling 
pathways downstream of the γδ TCR differ from αβ TCR signaling. 
 While Itk has the predominant role in TCR-dependent thymic selection 
events and in TCR-dependent activation of mature T cells, Rlk’s function is still 
uncertain.  Combined deficiency of Itk and Rlk in conventional αβ T cells results 
in a greater impaired signaling defect compared to conventional αβ T cells 
lacking only Itk.  Thus, this greater impaired signaling indicates a possible 
redundant role for Rlk in αβ TCR signaling (121).  Further evidence indicating Rlk 
can compensate for the loss of Itk includes a study by Sahu et. al.  In vivo studies 
have demonstrated that lack of Itk in CD4+ αβ T cells results in aberrant TH2 cell 
responses in an allergic model or upon challenge with eggs of S. mansoni (213).  
However, Sahu et. al., demonstrated that the aberrant TH2 cell response in Itk-/- 
mice can be rescued when an Rlk transgene is expressed (214).   
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Figure 4.1 Itk-/- γδ  T cells do not flux Ca2+ upon TCR activation. 
Intracellular Ca2+ concentration was determined by cross-linking wild type and Itk-
/- thymocytes with anti-CD3ε biotin.  Wild type and Itk-/- cells were stained with 
surface markers for TCRδ and then loaded with 16 µM of Fluo-3 (FL-1) and 16 
µM Fura Red (FL-3).  Baseline Ca2+ was taken for 2 min before stimulation via 
the TCR with 20 µg/ml streptavidin for 8 min.  Intracellular Ca2+ concentration 
was determined by gating on γδ T cells and calculating the mean fluorescence 
ratio of FL1:FL3 using FlowJo.  Results are representative of 2 independent 
experiments. 
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Therefore, this data indicates that it is possible for Rlk to compensate for Itk in its 
absence.   
 Interestingly, Martin Felices examined the serum IgE levels in Itk/Rlk-/- 
mice and found IgE serum levels elevated about ~2 fold higher than in Itk-/- mice.  
Surprisingly, the absence of γδ T cells does not rescue the elevated serum levels 
in Itk/Rlk-/- mice (data not shown).  Itk/Rlk-/- mice have an increase in the 
proportion and number of γδ T cells in the thymus but not in the spleen (Figure 
4.2 A and B).  Similar to Itk-/- mice, Itk/Rlk-/- mice also have elevated proportions 
of CD4+ γδ T cells in the thymus and spleen (Figure 4.3 A and B).  Examination of 
γδ T cell subsets in Itk/Rlk-/- mice showed an increase in proportion of V6 cells.  
Itk/Rlk-/- mice crossed to the IL-4 reporter mice (4Get) mice showed elevated 
levels of IL-4 message similar to 4Get mice lacking Itk (Figure 4.4 A) yet ex vivo 
stimulation of Itk/Rlk-/- γδ T cells demonstrated that these cells were unable to 
secrete IL-4, IL-10, IL-13 and IFNγ (Figure 4.4 B).  This could suggest that the 
TCR on Itk/Rlk-/- γδ T cells is not functional and that the γδ T cells may be 
spontaneously activated by other receptors such as Toll-like receptors (TLRs) 
(215) which has been shown to be the case for innate lymphoid cells.  Innate 
lymphoid cells can be classified similar to TH cells yet they do not have antigen –
specific receptors but are able to secrete similar cytokine profiles to conventional 
CD4+ αβ T cells (216).  Instead these cells have pattern recognition receptors 
(216, 217).  In addition this data suggests that while Rlk is not required for 
activation of cytokine loci, it is required for optimal cytokine production upon TCR   
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Figure 4.2 γδ  T cells in Itk/Rlk-/- mice have an increased proportion of γδ  T 
cells in the thymus 
 A and B Cells were prepared from thymus and spleen of wild type and 
Itk/Rlk−/−mice. (A) Cells were stained with anti-TCRγ and anti-TCRβ antibodies 
and analyzed by flow cytometry. Numbers in quadrants indicate the percentage 
of cells in each subset. Data are representative of 2 independent experiments 
with 2–3 mice per group. (B) Percentages and absolute numbers of TCRγ+ cells, 
based on TCRγ+TCRβ- staining, are indicated for the thymus and spleen. Each 
data point represents a different animal, and the bars represent the mean. p 
values were determined using the Mann-Whitney test. 
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Figure 4.3 Altered γδ  T cell subsets in the thymus and spleen of Itk/Rlk-/- 
mice. 
Cells were prepared from thymus and spleen of wild type and Itk/Rlk−/− mice. (A) 
CD4 versus CD44 expression on gated TCRγ+TCRβ- cells. (B) The percentages 
of CD4+TCRγ+ cells in the thymus (n=5–6 mice) and spleen (n=4–5 mice) are 
shown. Each data point represents a different animal, and the bars represent the 
mean. Data are representative of 2 independent experiments with 2–3 mice per 
group. Statistically significant differences are shown; p values were determined 
using the Mann-Whitney test. 
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Figure 4.4 Itk/Rlk-/- γδ T cells are impaired in the production of cytokines 
following ex vivo activation.  
Cells were prepared from thymus of 4Get, Itk-/--4Get, Rlk-/--4Get and Itk/Rlk-/-- 
4Get mice. (A) Cells from thymus were stained with anti-TCRγ, anti-TCRβ, anti-
Vγ1.1, anti-Vδ6.3, and anti-CD24 antibodies and Vγ1.1+Vδ6.3+ cells were further 
examined for CD24 expression by histogram. Histograms gated on CD24- 
Vγ1.1+Vδ6.3+ cells show GFP expression. (B) Lymph node and spleen cells from 
WT and Rlk/Itk−/− mice were pooled and TCRγ+ cells were isolated by cell sorting. 
5× 104 cells were stimulated with 10 µg/ml of anti-TCRγ antibody for 72 h, and 
supernatants were analyzed for the presence of IL-4, IL-10, IL-13, and IFNγ by 
cytometric bead array (CBA). 
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stimulation.  These preliminary results further suggest that TCR signaling in Itk-/- 
γδ T cells may still function via compensation by Rlk.  Further studies with Rlk-/- 
mice will be required to assess the function of Rlk in γδ T cell signaling. 
 Knowledge of TCR signal transduction has come from studies of αβ T 
cells given that γδ T cells are a rare population.  Earlier studies identifying 
molecules involved in αβ TCR signaling were performed using genetic models 
and biochemical studies to examine the effects of the absence of tyrosine kinase 
molecules on CD4SP and CD8SP αβ T cells and total γδ T cells.  Based upon 
these original studies, γδ T cell signal transduction is thought to be similar to αβ T 
cell signal transduction.  However, data in this thesis suggests that different γδ T 
cell subsets may have different requirements for signaling as mentioned 
previously.  Evidence suggests that αβ T and γδ T cell signaling share common 
features.  This evidence includes mouse models lacking proximal signaling 
molecules, such as Lck, SLP76 and LAT, that impact both αβ and γδ T cell 
generation (80, 179, 218, 219).  Interestingly, mutations of these molecules 
negatively affect the generation of αβ T cells, while the γδ T cell population is 
expanded.  Furthermore, mutations in LAT, which is lacking a critical tyrosine in 
cytoplasmic tail, and in SLP76, where tyrosine residues were mutated to 
phenylalanine at position 145 or 112 and 128, showed elevated levels of serum 
IgE along with V6 cells producing elevated levels of IL-4 (80, 179).  These data 
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indicate that while αβ and γδ T cells may share similar signaling molecules there 
is still distinct biochemical requirements between αβ and γδ TCR signaling. 
 Further evidence indicating αβ and γδ TCR signaling have distinct 
requirements has been demonstrated recently in mice lacking RasGRP1.  
RasGRP1, a guanine nucleotide exchange factor for Ras, is a critical upstream 
activator of the Ras-Erk1/2 pathway in αβ T cells following TCR engagement 
(220-222).  As expected αβ T cells in RasGRP1-/- mice were markedly 
decreased.  In contrast, γδ T cells did not require RasGRP1 for development.  
Closer examination of γδ T cell subsets in RasGRP1 deficient mice further 
demonstrated that V6 cells were increased by the absence of RasGRP1.  
Although the development of γδ T cells did not require RasGRP1, it was required 
for the generation and maintenance of an IL-17 producing subset of γδ T cells 
(CD27-CD44+) and an IFNγ producing subset of γδ T cells (CD27+CD44-) (223).  
Genetic studies with Lck, SLP-76, LAT, RasGRP1, and our studies with Itk 
indicate that these molecules are differentially required for αβ versus γδ T cell 
development.  Activation of Ras-Erk1/2 pathway induces early growth response 
(Egr) 1-3 which in turn promotes the activation of the transcription factor inhibitor 
of differentiation 3 (Id3) which are both involved in V6 cell development.  Thus 
the absence of RasGRP1 leads to decreased expression of Egr1/2 and Id3.  
Therefore, it is possible that these molecules are required for licensing or arming 
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of γδ T cells during their development to ensure proper activation maturation, 
which is a process required for NK cell development (224, 225).   
 We have assumed that the effects mediated by Itk in γδ T cells are due to 
signals downstream of the TCR and this appears to be true.  For example, in the 
absence of Itk, γδ T cells cannot flux calcium upon activation through the TCR 
(Figure 4.1).  However, given the mutations in Itk and signaling molecules 
previously mentioned tend to differentially affect various γδ T cell subsets, 
therefore Itk may have cell type specific functions.  Reinforcing this notion is that 
Itk is also downstream of FcεR1 in mast cells (143, 201).  Hence, it is possible in 
γδ T cells Itk is potentially downstream of an unidentified signal.   
 
A possible negative role for Itk in V6 cells 
 
 Based upon data derived from conventional T cell studies, Tec family 
kinases are typically thought to have a positive role in signaling (146, 201).  In 
contrast to αβ T cells, Chapter II demonstrated that γδ T cells are not reduced in 
the absence of Itk and are actually expanded similar to innate CD8+ T cells also 
found in the absence of Itk (187).  In addition to the V6 cells expanding in the 
absence of Itk, they had increased cytokine secretion as shown by ex vivo 
experiments.  Therefore, it is possible that Itk may be involved in a negative 
signaling pathway inhibiting the development or function of V6 cells. 
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 There is evidence to support Itk having a negative role in signaling.  Our 
lab and others have shown that Tec family kinases can have both a negative and 
positive role in mast cells.  In contrast to T and B cells, which predominantly 
express Itk and Btk respectively, mast cells express Btk, Itk, Rlk and Tec 
downstream of the high affinity receptor for IgE (FcεR1).  This receptor has a 
similar signaling pathway to the αβ TCR (141-143, 201).  Studies on the role of 
Btk in mast cells indicate that Btk has a positive role in mast cell signaling, and 
the absence Btk results in an effector function defect.  Examination of Itk in mast 
cells by Forssell et. al., indicated that Itk may also have a positive role in mast 
cell signaling (226).  However, in contrast to Forssell et. al., work performed in 
our lab (Yoko Kosaka, Markus Falk and John Evans) and others found that Itk 
has a predominantly negative role in mast cell signaling (227).  Unpublished work 
from our lab demonstrated increased PLCγ activation and cytokine secretion 
capabilities in mast cells lacking Itk.  In addition, Markus Falk demonstrated Itk 
can associate with and phosphorylate SH2 domain-containing inositol 5'-
phosphatase (SHIP)-1, Dok-1 and Dok-2, molecules that negatively regulate 
receptor signaling.  He has also demonstrated that Itk can co-localize with a 
negative signaling complex upon antigen-mediated stimulation. 
 If Itk plays a negative role in the regulation of mast cells, then Itk may also 
play a negative role in V6 cell function.  Evidence suggesting this negative role of 
Itk in V6 cells includes the abundant production of IL-4 and IL-13 in the absence 
of Itk.  Given that Itk can phosphorylate SHIP-1, Dok-1 and Dok-2 in mast cells, 
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these molecules may be involved in inhibiting the ability of V6 cells to secrete 
increased amounts of cytokine.  Additionally, SHIP-1, Dok-1 and Dok-2 are 
engaged downstream of the SAP/SLAM signaling pathway (228) which as 
previously mentioned is important for the development of both V6 and αβ iNKT 
cells.  The SAP/SLAM signaling pathway modulates both positive and negative 
signaling.  SAP/SLAM signaling can either positively regulate signals by 
activating NF-κB signaling through PKCθ, or reduce TCR signaling by 
dampening MAPK activation (93).  SAP/SLAM pathway has been shown to be 
important for not only αβ iNKT cell development (91, 92, 95, 199) but also V6 cell 
development (83, 191).  SLAM family receptors along with SAP have also been 
shown to mediate IL-4 production by CD4+ T cells (229, 230).  Traditionally Dok-1 
has been identified as an inhibitory molecule but Dok-1 has previously been 
reported as a positive regulator of IL-4 signaling and IgE response (231) though 
the exact pathway is unclear.  In a study by Inoue et. al., mice deficient in Dok-1 
displayed impaired responses to IL-4 along with impaired production of IgE in 
mice immunized with a T cell-dependent antigen.  Furthermore, overexpression 
of Dok-1 in a myeloid cell line was found to augment IL-4 induced proliferation.  
In accordance with this finding, a recent study of transgenic mice overexpressing 
Dok-1 under the control of the CD2 promoter led to the expansion of V6 cells 
(232).  Similar to V6 cells lacking Itk, Dok-1 overexpressing V6 cells were mostly 
PLZF+.  Therefore it is possible that Dok-1 exerts a negative feedback regulation 
on Itk activity.  Interestingly, this data would also suggest that Itk is negatively 
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affecting the SAP/SLAM signaling pathway through Itk’s interaction with Dok-1.  
In addition to the TCR signaling pathway thereby further indicating that the 
SAP/SLAM signaling pathway may directly interact with TCR signaling (Figure 
4.5). 
 In addition, as discussed in Chapter III, wild type V6 cells mature similar to 
αβ iNKT cells.  For example, both cell types undergo changes in cytokine 
production, up-regulate maturation markers and inhibitory receptors such as 
CD94 and Ly49E.  Functional studies on human γδ T cells have demonstrated 
that activation of KIRs and CD94/NKG2 receptors leads to the inhibition of 
cytotoxicity and cytokine receptors (233).  In mice, some γδ T cells express 
NKG2A-F/CD94, Ly49C/I, Ly49A, Ly49E and Ly49G2 in the thymus and 
peripheral tissues (234-237).  In αβ T cells, expression of Ly49 inhibitory 
receptors has been shown to confer inhibition on T cell activation and effector 
functions (238-240).  Contrastingly, Itk-/- V6 cells have decreased expression of 
Ly49 receptors and CD94.  Therefore, it is possible that the increase in cytokine 
production in V6 cells is due to decreased expression of the inhibitory receptors.  
It is unclear if Itk has a direct role in regulating the expression of these inhibitory 
receptors or if it is due to Itk affecting the maturation of V6 cells. 
 
Development of V6 cells from fetal precursors versus adult bone marrow 
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Figure 4.5 Model: Itk negatively regulates TCR pathway through interaction 
with the SAP/SLAM pathway 
 In wild type mice, the SAP/SLAM pathway is triggered in conjunction with the T 
cell receptor pathway and Itk negatively regulates the TCR signaling by acting 
upon the SHIP-Dok-1-Dok-2 complex in the SAP/SLAM pathway.  Upon 
activation of the SHIP-Dok-1-Dok-2 complex RasGAP is recruited which goes on 
to inhibit Ras activation, culminating in inhibition of the MAPK signaling.  
Therefore, it is possible that lack of Itk results in constant activation of the TCR 
pathway. 
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 Several studies have suggested that TCR signal strength determines T-
cell lineage commitment where stronger signals favor γδ T-cell development and 
weaker signals favor αβ T cell development (25-27).  Based upon this model one 
may expect, due to Itk possibly modulating TCR signal strength, T cells lacking 
Itk would receive reduced signal strength that would lead to reduced γδ T cell 
development.  In contrast, we show that this is not the case.  Instead there is an 
increase in the percentage and number of γδ T cells in the adult thymus and 
secondary lymphoid organs, and more specifically, an increase in the V6 cell 
population.  Signal strength studies have treated γδ T cells as a single cell 
lineage but it has recently been shown that some γδ T cell subsets are as 
molecularly distinct from each other as they are from αβ T cells (49).  In fact, 
closer examination of the gene profiles of immature γδ T cell subsets showed that 
they were already embedded with gene programs that were distinct for each 
subset.  These gene programs direct the subset-specific effector function.  This 
indicates that γδ function is molecularly programmed, and quite possibly, this 
programming is reinforced through the TCR (49).  Additionally, it has been further 
suggested that the V6 cell population may receive stronger TCR signals 
compared to other γδ T cell subsets, which in wild type mice could lead to 
negative selection during development (83).  Given that lack of Itk affects TCR 
signaling by dampening Ca2+ influx and activation of PLCγ, it was proposed that 
Itk deficiency may decrease signal strength.  This decrease in signal strength 
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would then allow V6 cells that would normally be negatively selected to survive.  
This escape of V6 cells from negative selection was thought to be the reason for 
their expansion in Itk-/- mice. 
 A recent study by Yuan et. al., could provide an alternate explanation for 
the expansion of V6 cells in mice lacking Itk.  V6 cells have been hypothesized to 
develop from late embryonic precursors and expand during neonatal life.  
Evidence arose for this model based upon the absence or minimal presence of N 
nucleotide addition at the junctions within the δ-chain due to lack of TdT 
expression in thymocytes until 3-5 days after birth.  During hematopoiesis, the 
major site of thymocyte development occurs from the fetal liver to the fetal spleen 
and bone marrow during late embryogenesis.  Fetal liver hematopoietic stem 
cells (HSCs) differ from adult bone HSCs both phenotypically and functionally 
and the developmental switch is thought to occur with in the first weeks after birth 
in mice (241, 242).  It has previously been shown innate-like lymphocytes such 
as certain subsets of γδ T cells preferentially arise from fetal liver HSCs (243).  
Yuan et. al. further elucidated the molecular basis of innate like cells preference 
to develop from fetal or neonatal precursors.  They reported Lin28b, which is 
known to specifically block the biogenesis of let-7 miRNA’s post-transcriptionally, 
is expressed specifically in mouse fetal liver and thymus but is not sustained 
during ontogeny and ectopic expression of Lin28 in adult HSCs endows them 
with the ability to mediate multi-lineage reconstitution resembling fetal 
lymphopoiesis.  Additionally, ectopic expression of Lin28 resulted in an increase 
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in development of V6 cells thereby providing further evidence that these cells 
may develop from a yet unidentified fetal precursor (244).  Since our data 
indicate that the absence of Itk allows for the development of V6 cells from adult 
HSCs, this suggests that Itk may negatively regulate Lin28b.  Therefore, it is 
possible that as a result of Itk deficiency, Lin28b expression may still be 
aberrantly expressed in adult HSCs and would promote the increase of V6 cells. 
 
Final thoughts 
 
 Further work needs to be undertaken to elucidate the effects of Itk on the 
fetal precursors of γδ T cells and determine if increased cytokine production is a 
cause or effect of aberrant maturation or function.  Future studies should include 
identifying the fetal precursor of V6 cells in order to better understand the role Itk 
has in the development of these cells.  In addition, sorting immature and mature 
subsets of neonatal γδ T cells for analysis of gene signatures will be useful 
identify the role Itk has to play in γδ T cell development.  Moreover, additional 
studies are required to differentiate the role of Itk in development versus function. 
 Aside from the role Itk plays in the development of V6 cells, the functional 
relevance of the V6 cells have not been studied in detail.  Previous studies in 
understanding the function of γδ T cells have focused on the population as a 
whole and have not examined the individual subsets of γδ T cells during an 
infectious response.  Studies using infectious models have generalized that 
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Vγ1.1+ cells, which includes both Vγ1.1+Vδ6.3- and V6 cells, primarily act a 
immunoregulatory and anti-inflammatory cells (34, 168, 245).  As shown by 
Narayan et. al., these are two distinct populations that could have differing 
functions during pathogen challenge (49).  Therefore, further studies with 
infectious models should focus on V6 and V1 subsets independently and on how 
Itk affects the immune response of V6 cells. 
 The data represented in this thesis illustrate a role for Itk in the 
development and function of V6 cells.  Itk is required for terminal maturation of 
these cells along with regulating their function.  Efforts are underway to develop 
pharmacological inhibitors of Itk for use as a potential target for asthma and other 
diseases of hypersensitivity (246).  A more thorough understanding of how Itk 
affects immune cells is required given recent findings of human patients with fatal 
Epstein-Barr Virus-associated lymphoproliferative disorder due to mutations in 
Itk.  Furthermore, understanding how Itk affects V6 cells during allergic 
responses and other diseases of hypersensitivity may benefit new strategies to 
block other disease processes where γδ T cells are involved. 
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Chapter V: Materials and 
methods 
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Mice: 
Itk-/- mice (129) on the C57BL/10 strain were previously generated in our lab and 
were either backcrossed >13 times to C57BL/10 background or were 
backcrossed 6 times to C57BL/6 background.  Wild type C57BL/10 or C57BL/6 
were purchased from Jackson laboratories, Charles River or Taconic 
laboratories.  Tcrd-/- mice (167) on the B57BL/6 background (Jackson 
Laboratories) were crossed to Itk-/- mice to obtain Itk-/-Tcrd-/- mice.   Wild type 
mice were Itk+/-Tcrd+/- littermates or C57BL/10 mice (Jackson Laboratories).  
β2m-/-, MHC2-/- and TCRβ-/- on the C57Bl/6 background (Jackson Laboratories) 
were crossed to Itk-/- mice to obtain Itk/β2m-/-, Itk/MHC2-/- and Itk/TCRβ-/- mice.  
SAP-/-, Itk/SAP-/- and Itk/Rlk-/- were a gift from P. Schwartzberg (National Human 
Genome Research Institute, National Institutes of Health, Bethesda, MD).  4Get 
mice (197) were crossed to Itk-/- , Rlk-/- and Itk/Rlk-/- mice to obtain Itk-/--4Get, Rlk-
/--4Get, and Itk/Rlk-/--4Get mice.  C57BL/6 or 4Get mice were used as controls.  
Mice were used between 2-3 months of age and were maintained at the 
University of Massachusetts Medical School under specific pathogen-free 
conditions after approval by the institutional animal care and use committee. 
 
Cell preparations, antibodies and flow cytometry 
Liver lymphocytes were isolated by collagenase digestion of minced liver 
followed by Ficoll gradient centrifugation; iIELs were isolated by incubation of 
cleaned intenstine followed by Ficoll gradient centrifugation.  The following 
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antibodies were purchased from BD Pharmingen: TCRδ(GL3)-FITC, Vγ2-FITC, 
Vγ3-FITC, Vδ6.2/6.3-PE, TCRβ-allophycocyanin, TCRβ-PE, TCRβ-biotin (bio), 
CD4-allophycocyanin, CD4-PE, CD8α-PerCP-Cy5.5, NK1.1-PE-Cy7, CD5-
CyChrome, IL-4-PE, IFNγ-allophycocyanin, B220-allophycocyanin, streptavidin 
(strep)-allophycocyanin, OX40-biotin, Rat anti-Mouse IgG1-FITC, CD49a-
AlexaFluor 647, IFNγ-AlexaFluor 700, Ly49F-biotin (bio).  TCRδ-allophycocyanin, 
ICOS-PE, NKG2A/C/E-FITC, TCRδ-PE-Cy5, TCRδ-PerCp eFluor 710, CD122-
PerCp eFluor 710, IL-4-PE-Cy7, Streptavidin (Strep)-PE-Cy7, CD49a-Alexa Fluor 
647, CD244.2-Alexa Fluor 647, TCRβ- allophycocyanin eFluor 780, CD24-eFluor 
450 and CD40L-allophycocyanin were purchased from eBioscience.  PNA-FITC 
was purchased from Vector Laboratories, Inc.  CD8α-PE-Texas Red was 
purchased from Invitrogen Molecular Probes.  CD1d-PBS57-PE and CD1d-
PBS57 allophycocyanin tetramers were provided by the National Institute of 
Allergy and Infectious Diseases Tetramer Facility.  Strep-Cascade Yellow was 
purchased from Invitrogen Molecular Probes.  The Vγ1.1 antibody (247), a kind 
gift of Dr. Pablo Pereira provided by Dr. Lynn Puddington, (Univ Conn Health Ctr) 
was purified from antibody producing cell lines by Bio-XCell.  Purified Vγ1.1 was 
conjugated to Alexa Fluor 647 with the Invitrogen Molecular Probes Alexa Fluor 
647 Protein Labeling kit or to biotin with FluoReporter Mini-Biotin-XX Protein 
Labeling kit also from Invitrogen Molecular Probes.  Vγ1.1-FITC was purchased 
from BioLegend.  The following antibodies were purchased from Santa Cruz 
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Biotechnologies: PLZF (D-9) and normal mouse IgG.  Cells (500,000-4,000,000 
events) were collected on a LSRII (BD Biosciences) flow cytometer.  Data were 
analyzed using FlowJo software (Tree Star). 
 
Quantitative real-time PCR 
Splenocytes and lymph node cells from 6-10 C57BL/10 or Itk-/- mice were pooled 
and γδ Tcells were enriched by labeling with anti-TCRβ biotin and anti-CD19 
biotin (BD Pharmigen) followed by depletion with anti-biotin magnetic beads 
(Miltenyi Biotec) on an AutoMACS machine.  Remaining cells were stained with 
anti-TCRγ-FITC, anti-NK1.1-PE, and anti-CD4-PerCp-Cy5.5 and sorted into 
TCRγ+NK1.1+, TCRγ+NK1.1-, TCRγ+CD4+ or TCRγ+CD4- populations on a 
FACSVAntage cell sorter (BD Biosciences).  RNA and cDNA were prepared from 
sorted cells as previously described (151).  Real time PCR was also performed 
as previously described (158) on an i-Cycler (Bio-Rad).  Primer sequences were 
as follows, β-actin sense 5’- CGA GGC CCA GAG CAA GAG AG -3’, antisense 
5’-CGG TTG GCC TTA GGG TTC AG -3’; eomesodermin sense 5'- TGA ATG 
AAC CTT CCA AGA CTC AGA -3', antisense 5'- GGC TTG AGG CAA AGT GTT 
GAC A -3’; T-bet sense 5’- GGG CTG CGG AGA CAT GCT GA -3’, antisense 5’– 
GGC TCG GGA TAG AAG AAA CG -3’; GATA-3 sense 5’- GAA GGC AGG GAG 
TGT GTG AA -3’, antisense 5’- TGT CCC TGC TCT CCT TGC TG -3’; IFNγ 
sense 5’- CCT GCA GAG CCA GAT TAT CTC -3’, antisense 5’- CCT TTT TCG 
CCT TGC TGT TGC -3’; IL-4 sense 5’- CGA AGA ACA CCA CAG AGA GTG 
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AGC T -3’, antisense 5’- GAC TCA TTC ATG GTG CAG CTT ATC G -3’; Itk 
sense 5’- CTC CGC TAT CCA GTT TGC TCC -3’, antisense 5’- GTC CTT GTT 
GAG CCA GTA GCC -3’; Rlk sense 5’- TCA ATC CAA CAG AGG CGG G -3’, 
antisense 5’- CCG CTC TCT TCA GTG CCA A -3’; and Tec sense 5’- 
GTT TGG AGT GGT GAG GCT T -3’, antisense 5’- GGT AAC GAT GTA GAT 
GGG C -3’; PLZF forward, 5’-TCT GAC AAA GAT GGG GAT GAT CC-3’, and 
reverse, 5’-CAG TAT TCC GTG CAG ATG GTA CAC-3’.  cDNA clones of each 
gene mentioned above were used for the generation of a standard curve.  A 
cDNA clone encoding PLZF was a kind gift from Dr. Albert Bendelac (Univ 
Chicago).   
 
Western Blot Analysis 
Purified cells were lysed in RIPA buffer and proteins were separated by SDS-
PAGE and transferred onto nitrocellulose membranes (Amersham Bioscience).  
Membranes were blocked and incubated with anti-GATA3, anti-T-bet (Santa 
Cruz) or anti-HSP70 (ABR affinity bioreagents) antibodies overnight at 4 degrees 
C, followed by HRP-conjugated secondary antibodies (Amersham Bioscience, 
Santa Cruz) for 1 hour.  Membranes were developed using the SuperSignal West 
Femta substrate (Pierce). 
 
In vitro stimulation assays 
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For the analysis in Chapter II, wild type and Itk-/- TCRγ+NK1.1+, TCRγ+NK1.1-, 
TCRγ+CD4+ and TCRγ+CD4- subsets from were activated in vitro with 10 µg/ml of 
anti-TCRγ biotin (BD Pharmingen) for 72 hours at 37 degrees, and supernatants 
were collected and IL-4, IL-10, IL-13 and IFNγ were measured by cytometric 
bead array (CBA) (BD Pharmingen).  Cells used for quantitative PCR were 
stimulated for 10 and 20 hours and examined for IL-4 and IFNγ mRNA.  For 
intracellular cytokine staining, cells from wild type and Itk-/- mice were stimulated 
as previously described (158).  In brief, cells were stimulated with 10 ng/ml PMA 
(Sigma-Aldrich) and 2 µg/ml ionomycin (Calbiochem) for 4-5 hours and incubated 
with Golgi-Stop and Golgi-Plug (BD Pharmigen) for 4-5 hours.  Cells were then 
surface stained for anti-TCRδ and anti-NK1.1, or anti-TCRδ, anti-Vγ1.1+, anti-
Vδ6.3+ or CD1d-PBS57 tetramer fixed, and permeabilized using a 
Cytofix/Cytoperm kit (BD Pharmingen), for studies in chapter II, or FoxP3 
fixation/permeabilization kit (e-Bioscience) for studies in chapter III, and stained 
for IL-4, IFNγ and PLZF.  For ICOS, CD40L and OX40 expression on γδ T cells, 
cells were stimulated for 24 hours with 10µg/ml anti-TCRδ.  Cells were then 
surface stained with anti-ICOS, anti-CD40L and anti-OX40 antibodies. 
 
Calcium Flux 
WT and Itk-/- thymocytes were first depleted for CD8 with Dynal beads 
(Invitrogen).  Cells were then stained with surface markers for TCRδ and then 
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loaded with Fluo-3 (FL-1) and Fura Red (FL-3) (Invitrogen).  Baseline Ca2+ was 
taken for 2 min before stimulation via the TCR with 20 µg/ml streptavidin (Thermo 
Scientific) for 8 min.  Intracellular Ca2+ concentration was determined by gating 
on γδ T cells and calculating the mean fluorescence ratio of FL1:FL3 using 
FlowJo.  Results are representative of 2 independent experiments. 
  
 
Serum analysis 
Blood was collected from wild type, Tcrd-/-, Itk-/-, β2m-/-, Itk/β2m-/-, MHC2-/-, Itk-/-
Tcrd-/-, Itk/MHC2-/-, TCRβ-/-, Itk/TCRβ-/-, SAP-/- and Itk/SAP-/- mice.  Serum was 
obtained by spinning the blood at 5,000 rpm for 5 min. and removing the 
supernatant.  IgE serum was analyzed by enzyme-linked immunosorbent assay 
(ELISA). 
 
Sample Preparation for Microarray analysis 
Samples were prepared for microarray analysis as described previously (49).  
Briefly, thymocytes were pooled from 4–30 mice and enriched for γδ T cells by 
depletion of CD8+ cells with magnetic beads and an autoMACS.  Cells were then 
stained and sorted with a FACSAria (~2 × 104 to 3 × 104 cells; >99% pure) 
directly into TRIzol (Invitrogen).  Independent triplicates were sorted unless 
indicated otherwise (complete sorting details available from the ImmGen Project).  
Population labels correlate with ImmGen populations as follows: MatV6.WT, 
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T.gd.vg1+vd6+24alo.Th; TotalV6. Itk-/-, T.gd.vg1+vd6+.Th.ITKko; MatCD4, 
T.4SP24-.Th; MatCD8, T.8SP24-.Th; NKT.44-NK1.1- (sorted in duplicate), 
NKT.44-NK1.1-.Th; NKT.44+NK1.1-, NKT.44+NK1.1-.Th; NKT.44+NK1.1+, 
NKT.44+NK1.1+.Th.  Note that all V6 cells in Itk-/- mice are CD24low. 
 
Cloning and Sequencing 
Liver Vγ1.1+Vδ6.3+ γδ T cells were sorted from wild type or Itk-/- mice.  Total RNA 
was isolated from wild type and Itk-/- Vγ1.1+Vδ6.3+ liver γδ T cells.  RNA was also 
isolated from 4Get and Itk-4Get mature Vγ1.1+Vδ6.3+ thymus γδ T cells that were 
GFP+CD122-, GFP+CD122+ and GFP-CD122+.  Cells were sorted either on a 
Moflo cell sorter (Cytomation) or a FACSVantage (BD bioscience).  Reverse 
transcription (RT) of 0.2 µg RNA was performed with qScript DNA Supermix 
(Quanta™). External δTCR regions were amplified from cDNAs by PCR. For 
PCR, primers were targeted just before the transmembrane region of δTCR (248), 
Vδ forward: 5΄- GAA TTC TGC AGG ATG GGG GCT TCT -3΄; Cδ reverse: 5΄- 
CTC GAG ATG CCT CCT CAC AGC CTG TTC TGT G -3΄. Conditions: RT cycle: 
25°C 5 min, 42°C 60 min, 85°C 5 min; PCR: 94°C 2 min, 94°C 15 sec, 63°C 15 
sec, 72°C 20 sec (40 cycles), 72°C 10 min.  Truncated δTCR region used in this 
study was cloned into pCR2.1®-TOPO® TA vector by TOPO® TA cloning kit 
(Invitrogen). PCR products amplified by Taq polymerase were gel-extracted 
(Qiagen) and 3’-T overhangs were directly ligated into the vector. All plasmids 
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were analyzed by sequencing with M13 forward and reverse primers. For 
reducing sequencing error, each sequence was aligned after confirmation of 2-
way (forward and reverse direction). 
 
 
Data analysis and visualization 
Two-tailed nonparametric Mann-Whitney tests were performed using Prism 
(Graph Pad software).  Data for microarray were analyzed and visualized as 
described previously (49).  Briefly, RNA processing and microarray analysis with 
the Affymetrix MoGene 1.0 ST array was performed at the ImmGen processing 
center (by ImmGen standard operating procedures; 
http://www.immgen.org/Protocols/ImmGen.  Cell prep and sorting SOP.pdf; 
Supplementary Notes 1 and 2).  Data were analyzed with modules of the 
GenePattern genomic analysis platform.  ConsolidatedProbeSets, a custom 
GenePattern module written by S. Davis (Harvard Medical School), was used for 
the consolidation of multiple probe sets into a single mean probe-set value for 
each gene.  Genes with differences in regulation were identified with the Multiplot 
module of GenePattern through the use of the average of all replicates.  Genes 
were considered to be regulated differently if they differed in expression by more 
than twofold, had a coefficient of variation among replicates of less than 0.5, had 
a Student's t-test P value of less than 0.05, and had a mean expression value of 
more than 120 in at least one subset in the comparison.  Heat maps were 
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generated by hierarchical clustering (HierarchicalClustering module of 
GenePattern) of data on the basis of gene (row) and subset (column) with the 
Pearson correlation for distance measurement.  Data were log transformed and 
clustered with pairwise complete linkage.  Data were centered on rows before 
visualization with the HeatMapViewer module of GenePattern. KEGG pathway 
analysis (Kyoto Encyclopedia of Genes and Genomes) was used for functional 
classifications through the DAVID portal. 
 
Bone Marrow Chimeras 
Bone marrow cells (1 x 107) from wild type or Itk-/- donors were injected into 
lethally irradiated (1000 rads) B6/SJL mice (Jackson Laboratories).  Ten weeks 
after reconstitution, donor thymocytes and splenocytes were analyzed by flow  
cytometery. 
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